← Browse

Centers for Disease Control and Prevention (CDC): History, Overview of Domestic Programs, and Selected Issues

Centers for Disease Control and Prevention (CDC): History, Overview of Domestic Programs, and Selected Issues
Updated March 22, 2024 (R47981)
Jump to Main Text of Report

Contents

Summary

The Coronavirus Disease 2019 (COVID-19) pandemic shined a spotlight on the Centers for Disease Control and Prevention (CDC), one of nine Public Health Service (PHS) agencies in the Department of Health and Human Services (HHS). CDC's role in and response to the pandemic have been the subject of numerous congressional hearings and oversight investigations.

History

CDC began as the Communicable Disease Center in 1946 focused on assisting states and localities in controlling communicable disease outbreaks. CDC's role has expanded over the decades to include programs aimed at disease prevention and health promotion more broadly. In 1980, when CDC was renamed the Centers for Disease Control (after two prior name changes), its official mission was to serve as HHS's "focus for developing and applying disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States." Over time, CDC evolved in response to an epidemiologic transition that occurred throughout the 20th century, in which the leading causes of death in the United States shifted from infectious diseases to chronic diseases and injuries. CDC also evolved as the field of epidemiology developed and scientists identified the preventable causes of a wide range of health challenges. Within the context of these developments, CDC was positioned to study preventable health challenges and to support programs to address them. CDC retains a dual responsibility for responding to emerging health threats, such as disease outbreaks, and for supporting ongoing disease prevention and health promotion efforts.

Organization and Programs

In FY2023, CDC and the Agency for Toxic Substances and Disease Registry had a program level of $14.5 billion, consisting of $9.3 billion for core public health programs and $5.2 billion for other programs funded by mandatory budget authorities such as the Vaccines for Children program and the World Trade Center Health Program. CDC currently comprises 23 centers, institutes, and offices (CIOs). Some of these CIOs focus on specific health areas (e.g., immunization and respiratory diseases), whereas others focus on specific functions and capabilities (e.g., laboratory science and safety). Within these CIOs, CDC's domestic public health activities generally fall within three categories: (1) support to state, local, tribal, and territorial (SLTT) health agencies, including assistance in investigating health threats and grant funding for health programs; (2) science and data, including CDC support for networks of laboratories and surveillance systems to monitor health threats and changes; and (3) health education and guidance. These activities cover a wide range of health topics, including infectious diseases, chronic diseases, injury, disability, occupational health, environmental health, and public health emergency preparedness and response. This CRS report does not focus on CDC's global health programs.

Authorization

CDC does not have a single, overarching statute that defines its overall mission, structure, and programs. Congress in 2022 codified the position of the CDC Director and its responsibilities through the PREVENT Pandemics Act (P.L. 117-328, Division FF, Title II). CDC as an agency has been shaped by reorganizations carried out under HHS departmental reorganization authorities. Many CDC programs cite general program authorizations in the Public Health Service Act (PHSA) as their statutory basis. Congress has often shaped CDC's programmatic focus areas through the annual appropriations process, in which CDC has received its funding through disease and program-specific accounts and line items. Some CDC programs are explicitly authorized in law, mostly in the PHSA. CDC also administers some federal public health regulations, though it is not primarily a regulatory agency. In addition, the CDC Director oversees the Agency for Toxic Substances and Disease Registry (ATSDR), a separate HHS operating division.

Reorganization and Reform

CDC has recently undertaken its own reorganization and reform effort through the Moving Forward initiative. Committee members in both the House and the Senate have solicited input on potential CDC reform. If Congress considers further legislative reform, Congress may contemplate the appropriate scope of the agency's mission and activities. Congress faces many policy options for CDC reform, including (1) awaiting results from the Moving Forward initiative, (2) establishing a process for CDC reform, and (3) further codifying the agency in statute.


The Coronavirus Disease 2019 (COVID-19) pandemic shined a spotlight on the Centers for Disease Control and Prevention (CDC), one of nine Public Health Service (PHS) agencies in the Department of Health and Human Services (HHS). CDC's role in and response to the pandemic have been the subject of numerous congressional hearings and oversight investigations.

With CDC the nation's lead agency for disease prevention and health promotion, CDC's primary domestic activities include providing support to state, local, tribal, and territorial (SLTT) health agencies, which are often at the forefront of public health. CDC also supports public health research, investigation, and data collection and provides public health education, guidance, and outreach to various audiences, including the general public, clinicians, and public health practitioners. These activities cover a wide range of health topics, including infectious diseases, chronic diseases, injury, disability, occupational health, environmental health, and public health emergency preparedness and response. In addition, the agency exercises regulatory authority in a few limited areas, such as in federal quarantine and inspection and occupational health and safety. CDC also administers a few health services programs, such as the Vaccine for Children program. Through its global health programs, CDC provides public health assistance to foreign governments (these activities are not a focus of this report).

Initially established in 1946 as a small center focused on controlling malaria and other vector-borne diseases, CDC evolved into the federal government's lead agency for disease prevention and health promotion in 1980. The agency grew through acquisition when many other preexisting federal public health programs, such as programs for tuberculosis and vital statistics, were transferred to CDC. In addition, Congress shaped CDC by enacting legislation aimed at strengthening its programs in certain areas, such as in injury prevention and control and public health emergency preparedness and response. Throughout CDC's history, CDC Directors have undertaken comprehensive reviews of the agency that informed subsequent reorganizations, for example in the late 1970s and most recently through the Moving Forward initiative, which began in 2022.1

All of this occurred against the backdrop of changing health concerns and a growing health prevention science field. Throughout the 20th century, an epidemiologic transition occurred in which the leading causes of death in the United States shifted from mostly infectious diseases to mostly chronic diseases and injuries. Epidemiologists adapted the methods developed for controlling communicable diseases to learn the preventable causes of a wide range of diseases and health problems. At the beginning of the 20th century, most diseases were viewed as a matter of fate. By the end of the 20th century, it was widely understood that many health problems could be prevented, whether through vaccines, bug spray, seatbelts, helmets, condoms, diet, exercise, or other measures. CDC positioned itself to study how to prevent health problems and to support prevention and control programs to address such challenges.2

During the 118th Congress, some Members of Congress have contemplated legislative reform of CDC following the agency's perceived performance during the COVID-19 pandemic.3 In particular, CDC has received scrutiny for its development and distribution of an initial laboratory test for COVID-19, as well as for its COVID-19 related health guidance, which critics perceived as confusing or favorable to certain interest groups.4 Some have asserted that CDC has lost public trust, citing polls showing declining favorable public views of CDC and other public health agencies.5 One independent investigative report characterized CDC's culture as academic and slow to respond to the urgent and changing emergency health situation posed by the pandemic.6 CDC has acknowledged some of these challenges in its own internal Moving Forward evaluation, and has since begun an internal reform process.7

There are many current views and proposals regarding potential CDC reform. Some have called for Congress to formally authorize CDC in statute.8 Although Congress shapes CDC's funded programs through appropriations each year, CDC does not currently have a single, overarching statute that defines the agency's mission, structure, and programs. As Representative Guthrie, chair of House Energy and Commerce Health Subcommittee (committee of jurisdiction for CDC) put it, "Congress has never, in a single voice, told the CDC what its mission is and is not."9 Others have called for Congress to establish a more formal process for considering potential CDC reform, for example, by establishing an external advisory group to evaluate the agency and propose reforms.10 Still others have called for patience, arguing that Congress should allow CDC to continue with its Moving Forward reform effort before considering any major legislative reform.11

This CRS report (1) provides an overview of CDC and presents selected issues for potential legislative reform; (2) describes CDC's history and contextualizes its evolution into the agency it is today, including a discussion of Congress's role in that evolution; and (3) outlines the CDC's current mission, organization, statutory authorizations, appropriations, and major domestic programs and activities. Information on the Agency for Toxic Substances and Disease Registry (ATSDR)—a separate HHS operating division authorized by Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA)—is included within the overall discussion of CDC programs.12 This CRS report does not focus on CDC's international programs and activities.

What Is "Public Health"?

In 1920, professor C.-E.A. Winslow defined the nascent concept of public health as

[t]he science and art of preventing disease, prolonging life, and promoting physical health and efficiency through organized community efforts for the sanitation of the environment, the control of community infections, the education of the individual in the principles of personal hygiene, the organization of medical and nursing services for the early diagnosis and preventive treatment of disease, and the development of social machinery which will ensure to every individual in the community a standard of living adequate for the maintenance of health.

CDC still uses this quote in its online Public Health 101 course today.

Other definitions of public health are similarly broad. For example, in 1988, the Institute of Medicine (today the National Academy of Medicine) defined public health as "fulfilling society's interest in assuring people can be healthy."

There are two key themes to definitions and ideas about public health. One is that public health focuses on preventing adverse health outcomes and promoting health more generally. Health promotion seeks to achieve an optimal state of wellness. The second is that public health focuses on efforts to improve health on a population and community-wide basis rather than on an individualized basis.

Sources: CDC, "Introduction to Public Health," https://www.cdc.gov/training/publichealth101/public-health.html, and C.-E.A. Winslow, "The Untilled Fields of Public Health," 1920, Science, vol. 51, no. 1306, pp. 23-33.

History and Context

Brief History

The public health system in the United States grew out of the sanitary reform movement of the 19th century, which was premised on the view that disease was caused by environmental conditions and lack of sanitation.13 Throughout the 1800s, states and cities established Boards of Health, often with broad powers to protect their residents' health.14 These boards generally focused on tackling potential sources of disease in the physical environment. They conducted surveys on the health conditions of their populations, performed inspections, investigated outbreaks, and disinfected possessions and locations thought to cause disease. By the end of the 19th century, 40 of the 45 states then in existence and many localities had established health departments. In the late 19th century, as scientific understanding of the germ theory of disease developed, many of these health departments established laboratories to identify and investigate the germs that caused disease. State and local public health agencies then expanded their roles, moving into surveillance (i.e., disease data reporting and monitoring), clinical care, and health education.15

Some trace the federal government's role in public health to the Marine Hospital Service (MHS), a system of federally run hospitals for merchant seamen first established in 1798.16 By the late 1800s the MHS began to play a role in preventing the introduction and spread of infectious diseases into the United States by ship—including smallpox, yellow fever, and cholera. In 1878, Congress enacted the first federal quarantine law to prevent and control the introduction of infectious diseases into the United States.17 The MHS's role then expanded to include public health activities, for example, federal quarantine, vaccination efforts, epidemic investigations, and medical examinations of immigrants.18 MHS was renamed the Public Health and Marine Hospital Service in 1902 and then the Public Health Service in 1912.19

Public Health Service Act of 1944

Even before CDC existed, Congress enacted the Public Health Service Act of 1944 (PHSA), which established the general set of federal public health authorities that, as amended, remain the basis of many CDC programs and regulations today.20 The PHSA consolidated and revised all preexisting federal laws pertaining to the U.S. Public Health Service (PHS), which had become part of the Federal Security Agency.21

As explained below in the "Statutory Authorizations" section, Title III of PHSA established a general set of federal public health authorities, including the authority to engage in research and investigations, to regularly publish health statistics and reports, and to assist states in preventing and controlling diseases.22 PHSA Title III also established the federal legal authorities for foreign and interstate quarantine and isolation to control communicable diseases. At the outset, the Surgeon General envisioned the federal government's role in public health as focused primarily on assisting the states with implementation of their public health programs. According to the statement of the Surgeon General, then head of the PHS, after its enactment

[T]he new law will facilitate the smooth operation of the Federal-State public health programs and will make it possible to expand State and local health services to the people. With a minimum of Federal administrative control to insure efficient and economical expenditure of Federal funds, State health authorities develop, organize, and administer their own programs; but on technical problems, planning and administration of comprehensive programs, and training of personnel they look to the Public Health Service for leadership and expert advice. 23

1946-1950: Establishment and Initial Years

The modern-day CDC began as the Communicable Disease Center in 1946.24 The center grew out of the Office of Malaria Control in War Areas (MCWA), which had been established in 1942 to prevent and control the spread of malaria around military training centers in the U.S. South.25 MCWA had been headquartered in Atlanta, GA, and CDC has been headquartered there since. By 1946, most of the military training centers had closed, but federal officials saw value in maintaining the expertise and capabilities of the office to prevent and control communicable diseases in the United States more generally.26 CDC was established administratively within the U.S. Public Health Service. Congress subsequently provided an appropriation in support of the new center.27

Initially, CDC was focused on vector-borne communicable diseases such as malaria.28 (Vector-borne diseases are caused by "vectors" such as mosquitoes, ticks, and fleas.29) In the following years, CDC's role expanded to assist states in addressing other outbreaks and health threats, including diarrheal diseases and polio.30 By 1949, the center had become a division of the Bureau of State Services within the PHS and had the following responsibilities:

This center … provides through the regional offices to State and local health agencies consultation and training in the development and operation of communicable disease control programs and public health laboratory practices. It plans, directs and evaluates in cooperation with State and local health agencies programs for the control of selected communicable disease; provides professional leadership, and makes available the latest professional techniques in connection therewith. The center conducts and evaluates studies and investigations in the development of new and improved procedural techniques for the prevention, detection, diagnosis, control and treatment of communicable disease, and enforces the medical aspects of the interstate quarantine regulations. 31

1950s-1960s: Expansion in Epidemiology, Communicable Disease, and Vaccination Programs

In its early years, CDC became known for the Epidemic Intelligence Service (EIS), which was established in 1951 to respond to the threat of potential biological warfare.32 EIS remains a core CDC program today.33 In the early 1950s, EIS was composed of early-career medical professionals who were trained by CDC to use epidemiology to control communicable diseases. Epidemiology uses statistical methods to study how often diseases occur in specific groups of people and to help trace the factors that contribute to disease. Epidemiology commonly relies on surveillance, or systematic and ongoing disease tracking and analysis. After training, EIS officers were available on-call to assist states with controlling communicable disease outbreaks. From the beginning, CDC received frequent requests for EIS assistance and the center became known for its ability to use applied epidemiology to help control disease spread.34

Reorganization Plan No. 1 of 1953 dissolved the Federal Security Agency and established the Department of Health, Education, and Welfare (HEW) in its stead (see textbox below). CDC was transferred to the new department. Throughout the early decades of its existence, CDC absorbed other programs and divisions within the PHS, for example, the Venereal Disease Division in 1957, the Tuberculosis program in 1960, the Morbidity and Mortality Weekly Report in 1961, and the Quarantine Service in 1967.35 As the Venereal Disease Division was absorbed into CDC, along with it came the public health advisors (PHAs), a cadre of early career health workers assigned to states who investigated sexually transmitted disease (STD) cases (then known as venereal disease). These young professionals implemented mass testing programs, interviewed patients, and traced patients' contacts—functions that remain core parts of public health programs today.36

In 1955, CDC responded to its first national health crisis. After the Salk polio vaccine became available, the PHS began to receive reports of polio cases among children who received the vaccine. CDC established a surveillance unit to monitor and investigate the cases and provide regular summaries of findings to state health officers and others involved in disease control. CDC eventually learned that 80% of the reported cases were associated with one product that constituted 10% of the total vaccine supply. A manufacturing issue was found and the product was pulled from the market. This incident, often called "the Cutter incident" (attributed to vaccine producer Cutter Laboratories), set a precedent for CDC to take a leadership role in national response during future emerging health threats and outbreaks, especially by leading national disease tracking and surveillance.37 CDC subsequently played a similar role in coordinating U.S. national disease tracking during the 1957-1958 Asian influenza pandemic, which caused several U.S. outbreaks.38

In the 1960s, CDC began to play a key role in federal immunization programs. Following the licensure of the Sabin oral polio vaccine in 1961, Congress enacted the Vaccination Assistance Act of 1962,39 which established the first federal grant program focused on several immunizations.40 The law added a new PHSA Section 317, which authorized a state grant program for intensive community vaccination programs against polio, diphtheria, whooping cough, and tetanus—a program that remains in place today and is commonly known as the "Section 317 Immunization Program."41 CDC became responsible for administering the new grant program. The agency provided funding and vaccines to states, and PHAs helped with program implementation. As the measles and rubella vaccines were licensed in 1963 and 1969, respectively, the two types of vaccines were integrated into the program. Incidence of vaccine-preventable disease fell throughout the 1960s.42

In the late 1950s, CDC began to provide public health assistance to other countries. At first, CDC provided periodic assistance during disease outbreaks. During the global Asian influenza pandemic in 1957-1958, CDC helped distribute testing supplies throughout the world, informed global laboratory practices, and tracked and summarized disease cases.43 In 1966, an international malaria eradication program was transferred from the Agency for International Development to CDC. CDC's international work subsequently expanded to include a smallpox eradication program and a famine relief initiative.44

CDC was briefly renamed the National Communicable Disease Center in 1967.45 By 1968, it became a center within the broader Health Services and Mental Health Administration agency. Its responsibilities were to support "a national program for the prevention and control of communicable and other preventable diseases."46

Reorganization Plans in 1953 and 1966

Both CDC and the U.S. Public Health Service (PHS) underwent several major reorganizations in the 1960s and 1970s. These reorganizations were underpinned by two federal reorganization plans submitted to Congress in accordance with the Reorganization Act of 1949:

  • April 1953: Reorganization Plan No. 1 of 1953 (67 Stat. 631) created the Department of Health, Education, and Welfare and transferred all functions and agencies of the Federal Security Agency, including the PHS and its CDC subunit, to the new department. At the time of the reorganization, the Surgeon General oversaw the PHS agencies. The plan also stated, "The [HEW] Secretary may from time to time make such provisions as the Secretary deems appropriate authorizing the performance of any of the functions of the Secretary by any other officer, or by any agency or employee, of the Department."
  • June 1966: Reorganization Plan No. 3 of 1966 (80 Stat. 1610) transferred the PHS from under the Surgeon General to the HEW Secretary. The plan "transferred to the Secretary of Health, Education, and Welfare … all functions of the Public Health Service, of the Surgeon General of the Public Health Service, and of all other officers and employees of the Public Health Service, and all functions of all agencies of or in the Public Health Service." It provided further that the Secretary "may from time to time make such provisions as he shall deem appropriate authorizing the performance of any of the functions transferred to him by the provisions of this reorganization plan by any officer, employee, or agency of the Public Health Service or of the Department of Health, Education, and Welfare." The plan abolished several PHS subunits, including the Bureau of State Services, which had been the home of the Communicable Disease Service since 1946. With regard to implementation of these abolishments, the plan stated that the "Secretary shall make such provisions as he shall deem necessary respecting the winding up of any outstanding affairs of the agencies abolished."

Following the Supreme Court ruling in INS v. Chadha, which cast doubt over the validity of reorganization plans, Congress enacted P.L. 98-532, which stated, "Congress hereby ratifies and affirms as law each reorganization plan that has, prior to the date of enactment of this Act, been implemented pursuant to the provisions of chapter 9 of title 5, United States Code, or any predecessor Federal reorganization statute." Thus, the 1953 and 1966 reorganization plans and the authorities they provided were ratified as law (42 U.S.C. §3501, note and 42 U.S.C. §202, note, respectively) at that time. These authorities remain in place today.

1970s: Becoming the Center for Disease Control and Expanding Scope

In 1970, CDC was renamed the Center for Disease Control. CDC's official responsibilities had widened to encompass "a national program for the prevention and control of communicable and vector-borne diseases and other preventable conditions, including those related to malnutrition."47 At the time, CDC's program areas consisted of (1) ecological investigations, (2) epidemiology, (3) foreign quarantine, (4) malaria, (5) nutrition, (6) small pox eradication, (6) training, (7) laboratory, and (8) state and community services (including those related to tuberculosis, other respiratory diseases, and STDs).48 This marked the first time that CDC's official responsibilities included noncommunicable health conditions. However, even before this change—as early as the 1950s—the CDC Director had assigned staff to study the epidemiology of noncommunicable health issues, such as cancer, malnutrition, and family planning.49

By the end of 1973, after a series of PHS reorganizations, CDC officially became one of the service's six main agencies (instead of a division within a larger program).50 Throughout the 1970s, the scope of CDC's work expanded as the agency established programs in the areas of nutrition, environmental health (e.g., lead exposure), smoking tobacco and health, occupational safety and health, oral health, cancer, health education, family planning, and birth defects.51 CDC acquired the PHS nutrition survey in 1971 (today known as the National Health and Nutrition Examination Survey, NHANES), the National Clearinghouse on Smoking and Health in 1972, and the National Institute for Occupational Safety and Health, along with lead paint poisoning prevention and urban rat control programs, in 1973.52

During the 1970s, CDC was credited with some public health successes. With assistance from CDC's global smallpox program, which relied on a strategy of surveillance and containment, smallpox was announced officially eradicated from the globe in 1979.53 By the end of the decade, the last human case of wild poliovirus (rather than vaccine-induced) was reported in the United States. Using NHANES data, CDC's environmental services division helped determine that blood lead levels were associated with lead concentration in gasoline, which led to regulations that decreased the amount of lead in gasoline and subsequently reduced blood lead levels in the population.54

CDC also faced scrutiny in the 1970s. In 1972, CDC was criticized for the so-called Tuskegee study begun in 1932 that left untreated syphilis in Black male patients for decades, even when treatment became available, in order to study progression of the disease. The agency had inherited the study with the transfer of the Venereal Diseases Division in 1957.55 CDC was also criticized for taking years to determine the cause of Legionnaires' disease, a severe form of pneumonia that caused several deadly outbreaks at the time. In addition, a 1976 mass immunization campaign to protect against a potential swine flu epidemic was suspended early when no influenza outbreak occurred and the vaccines were found to be associated with a rare but increased risk of Guillain-Barre syndrome, a severe neurological disorder.56 A subsequent review at the government's request found that the "program was marked by controversy, delay, administrative troubles, legal complications, unforeseen side effects and a progressive loss of credibility for public health authorities," and the review implicated the CDC Director in many of the challenges faced.57 Some have since defended the CDC Director's decisions, arguing that he made the right decisions based on available information.58

1980s: The Centers for Disease Control, Lead Disease Prevention Agency, and the HIV/AIDS Epidemic

In the late 1970s, CDC Director William Foege sought to shape CDC's future direction by soliciting public input and convening an advisory committee of outside experts and members of the public.59 The committee published a report in 1978 that identified the highest priority preventable health problems at the time, recommended strategies to address those problems, and made recommendations regarding CDC's role. The report recommended that CDC become the lead federal agency for disease prevention to address the full range of health problems facing the nation and the globe.60

The following year, the Surgeon General, with input from CDC, published the first Healthy People report, which laid out the major preventable health challenges facing the country and marked a national commitment to prevention.61 This report also set the stage for CDC to take a holistic approach to disease prevention and health promotion in the 1980s.

The Department of Education Organization Act,62 enacted in 1979, created the Department of Education as a separate department and renamed the Department of Health, Education, and Welfare as the Department of Health and Human Services. The following year, CDC was reorganized and renamed the Centers for Disease Control (with the "s" added) and its official mission (which remains in place today) became as follows:

The Centers for Disease Control (CDC) serves as the Department's focus for developing and applying disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States. 63

At the time, CDC consisted of programs and offices focused on (1) epidemiology, (2) biosafety, (3) international health, (4) laboratory improvement, (5) prevention services, (6) environmental health, (7) occupational safety and health, (8) health promotion and education, (9) professional development and training, and (10) infectious diseases.64 The key new additions included the Center for Health Promotion and Education and Center for Environmental Health, both of which incorporated preexisting CDC programs.65

Most prominently, the 1980s were marked by the HIV/AIDS epidemic.66 CDC first received reports of the new disease in 1981 and then conducted further epidemiologic and laboratory investigations. CDC quickly learned that the disease spread primarily among men who had sex with men and was likely caused by a blood-borne virus. CDC formed a taskforce on the disease and warned that it could become a major health issue.67

Budgetary constraints of the early 1980s limited CDC's ability to direct resources to the problem.68 By the mid to late 1980s, as the disease spread more widely, Congress had begun to dedicate more resources to HIV/AIDS programs. CDC's HIV prevention budget grew from $200 thousand in FY1981 to over $300 million in FY1988 (not inflation adjusted).69 CDC used its established methods of assessing risks and developing preventive programs in its efforts to control the epidemic. Throughout the 1980s, CDC established several new grant programs to fund HIV/AIDS prevention and control programs at the state and local level and spearheaded several informational campaigns on the disease.70 By FY1991, HIV/AIDS funding represented 37% of the agency's budget.71

Defining Public Health in America: Public Health in America Statement, 1994

In 1988, an Institute of Medicine report on the U.S. public health system found that it had fallen into "disarray." The report found general lack of agreement within the field on public health's mission and appropriate role. While the report made some initial recommendations, federal public health agencies then worked to further define public health's mission and scope. In 1994, the CDC Director and the Deputy Assistant Secretary for Disease Prevention and Health Promotion led a working group of PHS agency representatives and outside stakeholders to develop a consensus list of essential public health services. Ultimately, in fall 1994, HHS leadership and U.S. public health organizations adopted a Public Health in America statement that drew from the list, shown below. This framework, revised since 1994, has continued to serve as a basic foundation for public health practice in the United States.

Public Health in America Statement:

Vision: Healthy people in healthy communities

Mission: Promote physical and mental health and prevent disease, injury, and disability

Public Health:

  • Prevents epidemics and the spread of disease
  • Protects against environmental hazards
  • Prevents injuries
  • Promotes and encourages healthy behaviors
  • Responds to disasters and assists communities in recovery
  • Assures the quality and accessibility of health services

Essential Public Health Services:

  • Monitor health status to identify community health problems
  • Diagnose and investigate health problems and health hazards in the community
  • Inform, educate, and empower people about health issues
  • Mobilize community partnerships to identify and solve health problems
  • Develop policies and plans that support individual and community health efforts
  • Enforce laws and regulations that protect health and ensure safety
  • Link people to needed personal health services and assure the provision of health care when otherwise available
  • Assure a competent public health and personal health care workforce
  • Evaluate effectiveness, accessibility, and quality of personal and population-based health services
  • Research for new insights and innovative solutions to health problems

Sources: Institute of Medicine Committee for the Study of the Future of Public Health, The Future of Public Health, 1988, https://www.ncbi.nlm.nih.gov/books/NBK218215/; James A. Harrell and Edward L. Baker, "The Essential Services of Public Health," Leadership in Public Health, vol. 3, no. 3 (1994), pp. 27-30; The Public Health National Center for Innovations and the de Beaumont Foundation, Defining Public Health Practice: 25 Years of the 10 Essential Public Health Services, August 2019, https://www.astdd.org/docs/defining-public-health-practice-25-years-of-the-10-essential-public-health-services.pdf; and Bernard J. Turnock, "Chapter 5: Core Functions and Public Health Practice," in Public Health: What it is and How it Works, 5th ed. (Jones and Bartlett Learning, 2012), pp. 217-264.

1992-Present: Centers for Disease Control and Prevention

The Preventive Health Amendments of 1992 changed all statutory references to CDC in law to "Centers for Disease Control and Prevention," the name of the agency today.72 Since the early 1990s, CDC's programs have continued to evolve. As shown in the textbox above, discussions about the appropriate role and scope of public health in the late 1980s and early 1990s set the stage for issues on which CDC would focus in the following decades. This section discusses some of the agency's major areas of focus.

Vaccines for Children and other immunization programs. Following a measles epidemic from 1989 to 1991, where half of all cases occurred among unvaccinated preschool children, the Omnibus Budget Reconciliation Act of 199373 established the Vaccines for Children (VFC) program in Section 1928 of the Social Security Act.74 Through this Medicaid-financed program, CDC purchases recommended childhood vaccines in bulk at a federally negotiated discounted rate and distributes them to SLTT agencies to allow participating providers to furnish them at no cost to eligible children (see the "Vaccines for Children" section). Together with the long-standing PHSA Section 317 immunization program (see the "1950s-1960s" section), the VFC program helped expand CDC's role in supporting the infrastructure for immunization safety-net programs across the country. Starting in the 1990s, CDC also began to expand other immunization programs; for example, it invested in the nation's network of Immunization Information Systems, population-based data systems that help record and track immunizations received.75

Chronic disease. Since the 1990s, CDC's chronic disease prevention and control programs have expanded. In the early 1990s, Congress enacted several laws authorizing cancer programs at CDC. For example, in 1992, Congress enacted the Cancer Registries Amendment Act,76 which established the National Program of Cancer Registries—state-based systems to collect and track data on cancer.77 In addition, in 1990, Congress enacted the Breast and Cervical Cancer Mortality Prevention Act of 1990,78 which established a CDC state grant program to fund cancer screening among uninsured and underinsured women, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). More recently, starting in 2008, CDC also funded heart disease and stroke risk factor screenings for the population served by NBCCEDP, known as the WISEWOMAN program.79 In FY2023, CDC's Chronic Disease Prevention and Health Promotion program funded about 30 separate grant programs for state and local governments.80

Firearm injury and mortality prevention research and the "Dickey amendment": In the mid-1990's, some concerns arose surrounding perceived political biases of CDC research related to firearms and violence.81 Starting in FY1997, Congress added a new appropriations limitation that, at the time read, "none of the funds made available for injury prevention and control at the Centers for Disease Control and Prevention may be used to advocate or promote gun control."82 A version of this amendment, commonly known as the "Dickey amendment," has been included in annual appropriations every year since FY1997.83 While the language does not specifically mention research, CDC responded to the amendment and the surrounding political controversy by limiting its research related to firearms and violence.84 Some studies have found that since the limitation has been in effect, firearm-related violence has been underfunded and understudied relative to other leading causes of death based on mortality rates.85

Starting in FY2020 (P.L. 116-94), following several high-profile mass shootings, Congress has provided $12.5 million annually to CDC for "firearm injury and mortality prevention research." These amounts have been directed in appropriations report language for each of FY2020 through FY2023.86 During a 2019 House Appropriations subcommittee hearing, some Members of both parties expressed support for keeping the Dickey amendment in place as a "guardrail," while funding CDC research related to firearms and violence.87

Public health emergency and bioterrorism. In 1999, CDC established several new major public health emergency programs. For example, CDC launched the National Pharmaceutical Stockpile, now known as the Strategic National Stockpile (SNS), a federal stockpile of drugs, vaccines, and other medical products intended for emergency responses (SNS is now housed at the Administration for Strategic Preparedness and Response).88 In the same year, CDC established the Laboratory Response Network, a coordinated network of laboratories at the federal, state, and local level with specialized capabilities to detect biological, chemical, and other health threats.89

As discussed in greater detail in the "Example 3: Public Health Emergency Activities" section, Congress has enacted a series of statutes since 2000 that have likewise expanded CDC's role and programs in public health emergency management and response.

Major infectious disease outbreaks and epidemics. Since the early 2000s, CDC has responded to several major global and domestic infectious disease outbreaks. These have included the severe acute respiratory syndrome outbreak (SARS; 2003), H5N1 avian influenza (2005), H1N1 pandemic influenza (2009), Ebola virus (2014-2015 and 2018-present), Zika virus (2016), the Coronavirus Disease 2019 pandemic (COVID-19; 2020-2023), and mpox outbreak (2022). In particular, concerns about a potential avian influenza pandemic in 2005 prompted many congressional hearings, plans, and policy assessments on national preparedness for a pandemic that informed CDC's subsequent responses.90 Many of these infectious disease responses—especially the COVID-19 pandemic—have tested CDC's role as a lead public health agency with expertise in infectious disease control and response, as explained further in the next section.

The Affordable Care Act and public health programs. The Patient Protection and Affordable Care Act (ACA91), enacted in 2010, was landmark health policy legislation that made many changes across federal health policy areas, including public health prevention and health promotion programs. The ACA authorized several new programs at CDC and codified several existing programs, including programs related to infectious diseases, diabetes prevention, and oral health.92

The ACA established a new mandatory budget authority for public health, the Prevention and Public Health Fund, "to provide for expanded and sustained national investment in prevention and public health programs to improve health and help restrain the rate of growth in private and public sector health care costs."93 That ACA section has appropriated funding annually, and as directed through annual appropriations, CDC has received the majority of this funding in recent years (e.g., $903 million to CDC in FY2023 out of $943 million total). This PPHF, combined with annual discretionary appropriations, serves as one of CDC's main sources of budget authority for public health programs.94

Current Status: The COVID-19 Pandemic and CDC's Moving Forward Initiative

During the COVID-19 pandemic, CDC took a highly visible role in educating the public about the virus and disease, collecting and tracking COVID-19 data, informing COVID-19 research and science, and issuing health guidance aimed at prevention and control. CDC also advised and coordinated many national public health programs, for example, testing, contact tracing, and vaccination efforts.95 The agency also used its regulatory authorities to issue public health orders during the pandemic, for example, an order requiring vaccination for international travelers to the United States and an order restricting the entry of certain noncitizens into the United States, commonly known as the "Title 42" entry restrictions.96

CDC and its actions during the pandemic have been the subject of numerous congressional hearings, oversight reports, and independent evaluations. In particular, CDC received scrutiny for its development and distribution of an initial laboratory test for COVID-19, as well as for its COVID-19 related health guidance, which critics perceived as confusing or favorable to certain interest groups.97 Some have asserted that CDC has lost public trust, citing polls showing declining favorable public views of the agency.98 One independent investigative report characterized CDC's culture as academic and slow to respond to the urgent and changing emergency health situation posed by the pandemic.99 Some have argued that the challenges CDC faced during the pandemic are attributable to a general lack of funding and capacity at CDC and, more broadly, in the public health system.100

In April 2022, CDC's leadership began a review and reform process, entitled Moving Forward, aimed at modernizing the agency to better achieve its mission. The initial review consisted of two components: a scientific and programmatic review and an organizational structure review. Broadly, the structural review found that CDC's academic approach sometimes hindered its ability to rapidly respond to an evolving threat such as the COVID-19 pandemic. In particular, the review found that the agency's incentive structures rewarded scientific publications over impact and actions. The review also found that the agency could benefit from becoming more flexible and less siloed by health area or program.101 In February 2023, CDC finalized an agency reorganization following recommendations from the evaluations (see the "Organization" section for more details).102 The agency stated that, as a result of the initiative, it was working through 160 reform actions targeted to be completed by January 2024. These included, for example, website changes, laboratory capacity reforms, CDC-wide response training, and data modernization.103

Figure 1. CDC Organizational History: A Timeline

media/image4.png

Source: See the sources in the "History and Context" section of this report.

CDC's Evolution in Context

As shown in CDC's organizational history in Figure 1, the scope of the agency has greatly expanded since it was first established. CDC evolved and grew as an agency as the fields of public health and prevention science grew. In the first half of the 20th century, a greater scientific understanding of the germ theory of disease helped facilitate the communicable disease control science and methods for which CDC became known.104 CDC cultivated specialized expertise within the federal government in disease control, specifically in the developing fields of epidemiology and surveillance.105

Throughout the 20th century, the field of public health became more specialized, and distinguished itself from the field of medicine. Public health grew to encompass research into the social, environmental, and biological determinants of health, broadly, along with the practice of addressing those determinants.106 The 20th century also saw a shift in the burden—or overall health impact—of diseases. In the early 1900s, infectious diseases were the major causes of death in the United States. By midcentury—including by the time CDC was established in 1946—chronic conditions such as cancer and heart disease became the leading causes of death (often called the epidemiologic transition). Throughout the 20th century, even after 1946, mortality rates from infectious diseases fell, except during epidemics such as the HIV/AIDS epidemic and the COVID-19 pandemic. 107 As the major health concerns changed, so too did the field of public health and its focus areas. 108

In particular, evolution in the field of epidemiology—in which CDC cultivated distinct expertise—helped expand the scope of public health.109 Throughout the 20th century, epidemiologists learned to apply the scientific methods developed for communicable diseases to a wide range of diseases and conditions, including chronic diseases and injuries. Epidemiologists helped scientifically determine the risk factors that led to poor health; for example, the scientific relationships between smoking tobacco and lung cancer, folic acid intake and birth defects, and seat belt use and motor vehicle fatalities.110 This scientific understanding could then be used to develop public health interventions to address risk factors, such as health education and promotion campaigns.111 CDC was in a position to support both the data collection and research into risk factors, as well as some of the programmatic interventions to address them.

Within this context, CDC expanded in scope as an agency. As recounted in the brief history here, CDC sometimes expanded through acquiring existing programs and through departmental reorganizations. CDC fit these diverse programs under the broad umbrella of public health such that by the 1980 reorganization, CDC became HHS's focus for developing and applying disease prevention and control and for promoting health more broadly.112 The 1980 reorganization was also preceded by a broader reassessment of CDC's role in addressing preventable health challenges. In addition, as illustrated in the next section, Congress has at times facilitated new or enhanced programs and roles for CDC through both the authorizations and the appropriations process.

Congress's Role in Shaping CDC

As noted above, CDC has been substantially shaped by a series of administrative reorganizations throughout the 20th century. Congress has also played a role in shaping the agency. Much of this role has been to provide the agency with annual appropriations, often through disease- or program-specific accounts and budget lines, that have shaped CDC's programmatic focus areas.113 In addition, Congress has at times enacted authorizing legislation aimed at shaping CDC's programs and functions. Examples of each of these methods of shaping CDC are included below. Most recently, Congress formally authorized the position of the CDC Director and required agency-wide strategic planning through the PREVENT Pandemics Act.114

Appropriations

Congress has provided annual appropriations for CDC programs since the agency was first established (see the "1946-1950: Establishment and Initial Years" section). Through this process, Congress has often appropriated funding based on certain health or program areas. Earlier in its history, the entire U.S. Public Health Service received appropriations for specific public health functions; the appropriations laws did not specify the specific operating divisions or units to carry out such activities. For example, in the appropriations act for FY1960,115 the Public Health Service received appropriations for "Assistance to States," "Control of Venereal Diseases," "Control of Tuberculosis and Communicable Disease Activities," among other purposes.

In 1974, after CDC became one of five main PHS agencies, appropriations laws began to appropriate funds to CDC more directly.116 In recent decades, Congress has appropriated funds to specific accounts within CDC aligned with certain broad health areas (e.g., immunization) or activity areas (e.g., epidemic services). Within these accounts, Congress often specifies funding for particular programs through appropriations report language (see Figure 2). The number and specificity of CDC's programmatic budget lines within accounts have grown over the past several decades. To illustrate, in FY1990, the conference report accompanying CDC appropriations specified funding levels for 18 programs within CDC accounts.117 In FY2023, the explanatory statement accompanying CDC appropriations specified funding levels for more than 140 line-items within CDC accounts (in both accompanying tables and text).118

Figure 2. How Congress Shapes CDC Programs Through Appropriations: Illustrative Example

media/image5.png

Source: CRS analysis of CDC appropriations.

Authorizing Legislation: Case Studies

At times, Congress has enacted legislation that has created new programs or changed CDC's authorities and functions. Three illustrative examples are explained in the following case studies. In the first example (injury prevention and control), Congress authorized a specific type of activity at CDC. In the second example (the National Center on Birth Defects and Developmental Disabilities), Congress explicitly established a new center at CDC by statute. In the third example (public health emergency activities), Congress established and shaped CDC's roles and programs in public health emergency preparedness and response through a series of laws that have been periodically reauthorized since 2000.

Example 1: Injury Prevention and Control

A 1985 report requested by Congress, Injury in America: A Continuing Public Health Problem, called for addressing injuries—including traffic-related injuries, falls, drowning, poisoning, violence, and other injuries—as public health problems, including by increasing research into the causes of injuries and the means to prevent them. The report recommended that a Center for Injury Control be established within CDC.119 Congress then enacted the Injury Prevention Act of 1986,120 which formally authorized CDC injury prevention and control activities in the Public Health Service Act.121 CDC's budget for injury prevention and control grew from $10 million in 1985 to $49.2 million in 1997 (not inflation adjusted). CDC established the National Center for Injury Prevention and Control in 1992.122

Example 2: National Center on Birth Defects and Developmental Disabilities

The Children's Health Act of 2000123 amended the PHSA to establish, in statute, the National Center on Birth Defects and Developmental Disabilities (NCBDDD) within CDC.124 According to CDC, the center was created in response to "strong advocacy efforts by external organizations whose view was that children's health issues were not being adequately addressed by CDC."125 In 2001, CDC moved the staff and resources of the preexisting Division of Birth Defects and Developmental Disabilities out of the National Center for Environmental Health, where it had been located for over 30 years, to become the new NCBDDD.126

Example 3: Public Health Emergency Activities

Beginning in 2000, Congress enacted a series of laws aimed at strengthening public health emergency capabilities within CDC and other HHS agencies. The Public Health Threats and Emergencies Act, enacted in 2000, included several provisions that required assessments of national public health emergency capacity and needs.127 The law also authorized grants to support state and local capacity to address health threats. In addition, the law authorized CDC to improve its laboratories and other facilities to support public health emergency capacity. It included a section that stated,

Congress finds that the Centers for Disease Control and Prevention have an essential role in defending against and combatting public health threats of the 21st century and requires secure and modern facilities that are sufficient to enable such Centers to conduct this important mission.128

The committee report accompanying the Senate bill expressed concern that many state and local health departments would not be able to rapidly and effectively respond to a major outbreak in their communities. The report also noted that federal agencies, such as CDC, needed updated laboratories, facilities, and technologies for public health emergency response. In particular, many buildings at CDC had not been updated since just after World War II, and many of CDC's laboratories lacked capabilities required for research with dangerous infectious agents.129

Following the 9/11 terrorist attacks and the anthrax incident of 2001, Congress enacted the Public Health Security and Bioterrorism Preparedness and Response Act of 2002,130 which sought to further enhance public health emergency capacity. The law enhanced CDC's authorities to improve its laboratory facilities and surveillance networks to respond to public health threats. The law also authorized CDC's Public Health Emergency Preparedness (PHEP) cooperative agreement program in PHSA Section 319C-1, a grant program that funds public health emergency preparedness and response capacity in state and local health departments. This law set the stage for the Pandemic and All Hazards Preparedness Act of 2006 (PAHPA),131 which reauthorized and further amended the CDC provisions enacted in 2002. PAHPA has since been reauthorized twice, in 2013132 and 2019,133 and both times included additional provisions that addressed CDC programs related to public health threats.

The programs authorized by these laws have helped develop the field of public health emergency preparedness and response across the country. CDC has established 15 foundational capabilities that SLTT health agencies should have in order to prevent, protect against, respond to, and recover from public health emergencies such as infectious disease outbreaks and chemical, biological, nuclear, and radiological threats.134 These include functions such as emergency coordination, public health laboratory testing, and medical countermeasure (e.g., vaccines, treatments) dispensing and administration. SLTT health agencies are required to invest in these capabilities as a condition of receiving CDC PHEP grants. These programs have brought frameworks from the emergency management field into public health responses to various health threats, such as infectious diseases. Much of the evolution in the field of public health emergency management was driven by legislation enacted by Congress.135

Agency Overview Today

The following sections provide an overview of CDC as an agency today, including its mission, organization, authorizations, funding, and key activities.

Mission

Like several other agencies established by executive action, CDC does not have an overall mission or purpose defined in statute. In 2022, Congress articulated the breadth of the agency's work in the PREVENT Pandemics Act.136 The act codified the position of the CDC Director and provided that the Director is to implement responsibilities and authorities that are

related to the investigation, detection, identification, prevention, or control of diseases or conditions to preserve and improve public health domestically and globally and address injuries and occupational and environmental hazards, as appropriate.137

As established in Federal Register notices, CDC's official mission statement is as follows:138

The Centers for Disease Control and Prevention (CDC) serves as the national focus for developing and applying disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States.

In addition, CDC's stated mission on its website is as follows:

CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.

CDC increases the health security of our nation. As the nation's health protection agency, CDC saves lives and protects people from health threats. To accomplish our mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.139

CDC's mission statements comprise two predominant themes. First, the agency is responsible for overall health promotion and disease prevention. Second, the agency is responsible for health security and response to specific health threats.

Organization

As shown in Figure 3, CDC is organized into many centers, institutes, and offices (CIOs). Some of these CIOs focus on specific public health challenges (e.g., injury prevention and control), while others focus on general public health capabilities (e.g., state, tribal, local, and territorial public health infrastructure and workforce).

Figure 3. CDC Organization Chart

media/image6.png

Source: Adapted by CRS from CDC, "CDC Organization Chart," https://www.cdc.gov/about/pdf/organization/cdc-org-chart.pdf, updated as of February 23, 2023.

Notes: HIV = Human Immunodeficiency Virus; STD = Sexually Transmitted Disease; TB = Tuberculosis.

CDC most recently underwent a reorganization in 2023 as a part of its Moving Forward initiative.140 According to CDC, the reorganization was informed by feedback from staff and partners on how CDC could change its structure to better respond to public health challenges. The reorganization included the following key changes:141

  • CDC created the new National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce, intended to improve collaboration with local health departments and public health partners.
  • To align with its "core capabilities," CDC established new offices within the Office of the Director: the Office of Health Equity; the Office of Public Health Data, Surveillance, and Technology; the Office of Laboratory Science and Safety; and the Office of Readiness and Response.

Statutory Authorizations

As discussed above, CDC is an administratively established agency that has been shaped by congressional appropriations and some program authorization statutes. Congress has mostly shaped CDC's programs through specifying and directing funding through the annual appropriations process. The agency, like several other agencies established by executive action, does not have a single, overarching statute that defines its overall mission, structure, or programs.142 CDC's programs are authorized by general and program-specific laws, mostly in the PHSA. The position of the CDC Director and its responsibilities were codified into law in December 2022.143

CDC Director Authorization

Authorized in PHSA Section 305,144 added in December 2022, the CDC Director is responsible for the overall direction of CDC and the Agency for Toxic Substances and Disease Registry, as well as the management and operation of its programs.145 This law made the CDC Director a presidentially appointed and Senate-confirmed position, effective January 20, 2025. The authorization does not define the specific programs for which the CDC Director is responsible; instead, the law defines the general scope of the Director's authorities and responsibilities (see the "Mission" section).

PHSA Section 305 also requires the CDC Director to develop a strategic plan every four years to identify overall priorities and objectives for the agency.

General Program Authorizations

The general public health authorities of the Public Health Service Act, many of which were established in 1944, have long underpinned CDC's activities (see the "Public Health Service Act of 1944" section). CDC's current programs and structure evolved from a series of reorganizations and acquisitions, as discussed in the "Brief History" section. Many CDC programs across a wide range of health areas cite general and permanent PHSA Title III authorities of the HHS Secretary as their statutory basis, including the following:

PHSA Section 301 (42 U.S.C. §241): Research and Investigation. This section allows PHS agencies, including CDC and the National Institutes of Health (NIH), to conduct, coordinate, and fund research and investigations "relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and impairments of man." Under this authorization, PHS agencies may award grants and contracts for research, publish studies and research-based health information, and make available PHS facilities for research, among other research activities. CDC cites PHSA Section 301 as one authorizing statute for all of its CIOs and accounts.146

PHSA Section 307 (42 U.S.C. §242l): International Cooperation. This section authorizes the HHS Secretary to engage in international cooperation in health research, health statistics, health care technology, health care services, and other activities, especially for HIV/AIDs, tuberculosis, malaria, and other preventable infectious diseases. The section authorizes participation in international meetings, the award of grants, and the exchange of scientists and other fellows with other countries, among other cooperative activities. CDC cites PHSA Section 307 as one authorizing statute for all of its CIOs and accounts.147

PHSA Section 310 (42 U.S.C. §242o): Health Conferences and Health Education Information. This section requires the HHS Secretary to call annually a conference among state health authorities. The section also authorizes the Secretary to periodically issue information related to public health and requires the Secretary to publish weekly reports on the health conditions in the United States and other countries and other health information. CDC cites PHSA Section 310 as one authorizing statute for all of its CIOs and accounts.148

PHSA Section 311 (42 U.S.C. §243): Federal-State Cooperation in Communicable Disease Control and Public Health Matters. This section authorizes the HHS Secretary to provide and accept assistance in enforcing quarantine and other health authorities at the federal and state level, and to assist states (and their political subdivisions) in controlling communicable diseases and in other public health matters. The Secretary may provide related assistance and training to states, and may make available resources, such as personnel and medical supplies, to the states that "may be effectively used to control epidemics of any disease or condition and to meet other health emergencies or problems." CDC cites PHSA Section 311 as one authorizing statute for all of its CIOs and accounts, except "Public Health Scientific Services" and "Global Health."149

PHSA Section 317 (42 U.S.C. §247b): Project Grants for Preventive Health Services. This section allows the HHS Secretary to award grants for preventive health service programs to states, their political subdivisions, and other public health entities. Recipients may receive supplies, including vaccines and other preventive agents, in lieu of grant funds. Subsection (k)(1) specifically authorizes vaccination grant programs. Subsection (k)(2) authorizes grant programs for the prevention and control of diseases and conditions more broadly, including for research, demonstration projects, public information and education programs, and other programs aimed at health professionals. Subsection (l) provides authority to purchase recommended adult vaccines at a negotiated rate, to be provided in lieu of grant funds at the recipient's request. CDC cites PHSA Section 317 as one authorizing statute for all of its CIOs and accounts, except "Global Health" and "Public Health Preparedness and Response."150

Program-Specific Authorizations

Three CDC centers and institutes and ATSDR are explicitly authorized in law:

  • National Institute for Occupational Safety and Health (NIOSH), authorized by the Occupational Safety and Health Act of 1970 (29 U.S.C. §671).
  • National Center on Birth Defects and Developmental Disabilities (NCBDD), established in PHSA Section 317C (42 U.S.C. §247b-4).
  • National Center for Health Statistics (NCHS), established in PHSA Section 306 (42 U.S.C. §242k).
  • ATSDR, established by the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA; 42 U.S.C. §§9601 et seq., at §9604(i)).151

Some of these components were initially established separately from CDC—NIOSH and NCHS, in particular—and were then later transferred to CDC (see the "History and Context" section). Some CDC offices, such as the Office of Women's Health (PHSA Section 310A)152, are also authorized in law.

CDC also administers program-specific statutes throughout the PHSA and other laws.153 Some of these statutes are directed at CDC, for example, the authorization for the Epidemiology and Laboratory Capacity grant program in PHSA Section 2821.154 Others are directed at the HHS Secretary but carried out by CDC by delegation, for example, an authorization for activities related to the prevention and control of sexually transmitted diseases in PHSA Section 318.155

The program-specific authorizations that CDC administers vary in terms of specificity, as illustrated in Table 1. Some, such as PHSA Section 318, authorize a general set of public health activities (e.g., research, demonstration projects, and education) with respect to a certain health area (e.g., sexually transmitted diseases). Others authorize and delineate a specific program to be administered by CDC, such as the authorization for the Public Health Emergency Preparedness cooperative agreement in PHSA Section 319C-1, which sets forth eligible awardees, a program funding formula, and other requirements for the grant program.

Many of CDC's specific program authorizations have expired authorizations of appropriations. CDC's FY2025 Congressional Budget Justification lists 29 programs with authorizations of appropriations that have expired in FY2023 or earlier.156 In general, when Congress appropriates funds for a program whose funding authorization has expired, that appropriation provides sufficient legal basis to continue the program during that period of availability absent indication of congressional intent to terminate the program.157

Table 1. Selected CDC Program Authorizations

Title

PHSA and U.S. Code Section

Summary

Projects and programs for the prevention and control of sexually transmitted diseases

PHSA §318; 42 U.S.C. §247c

Allows the HHS Secretary to conduct many activities related to the prevention and control of sexually transmitted diseases, including, among others, technical assistance and training; research and demonstration grants; prevention and control program grants; and fostering innovative interdisciplinary approaches.

Epidemiology-laboratory capacity grants

PHSA §2821; 42 U.S.C. §300hh-31

Requires the CDC Director to establish an Epidemiology and Laboratory Capacity Grant Program for state, local, and tribal health departments to strengthen epidemiologic and laboratory capacity for response to infectious diseases and other conditions of public health importance.

Oral health promotion and disease prevention

PHSA §317M; 42 U.S.C. §247b–14

Authorizes CDC grants to states and tribes for oral health purposes, including community water fluoridation, school-based dental sealant programs, and oral health program leadership and data collection.

Compilation of data on asthma

PHSA §317I; 42 U.S.C. §247b-10

Requires CDC to conduct surveillance activities to collect and publish data related to asthma's health impact and clinical management.

Improving state and local public health security

PHSA §319C-1; 42 U.S.C. 247d-3a

Authorization for the Public Health Emergency Preparedness cooperative agreement program. Authorizes CDC to award cooperative agreements to state and local jurisdictions for public health emergency preparedness and response. Requires awardees to submit preparedness and response plans, report annually on progress against health security goals, and to conduct certain activities, such as drills and trainings for staff. Specifies a funding formula and requires states to maintain public health security expenditures.

Source: Selected from CDC, "Authorizing Legislation," Congressional Justification: FY2024, pp. 54-61, https://www.cdc.gov/budget/documents/fy2024/FY-2024-CDC-congressional-justification.pdf.

Note: CRS selected a sample of CDC program authorizations to provide an illustrative view of how the agency's programs are authorized.

Appropriations

In FY2023, CDC/ATSDR had a total program level of $14.5 billion, consisting of $9.3 billion in core public health program funding for CDC and ATSDR and an estimated $5.2 billion for other mandatory spending programs.158 CDC receives most of its core program funding through the annual Departments of Labor, HHS, and Education, and Related Agencies (LHHS) Appropriations Act. CDC receives LHHS appropriations through accounts that align mostly with the titles of its CIOs. ATSDR is funded by the Departments of the Interior, Environment, and Related Agencies Appropriations Act. CDC also administers several programs that are funded by mandatory spending authorities, such as the Vaccines for Children program and the World Trade Center Health Program (see the "Health Services Programs" section). Congress has also provided CDC with supplemental emergency funding during public health emergencies and other incidents.

Given that many CDC programs are based in general authorities, Congress often uses the appropriations process to inform CDC's programs. Appropriations reports accompanying CDC annual appropriations usually specify programmatic funding levels within CDC accounts, though to varying levels of detail depending on the program and account. For more information on CDC funding, see CRS Report R47207, Centers for Disease Control and Prevention (CDC) Funding Overview.

Activities

CDC uses its general and specific program authorizations, as well as the appropriated funds it receives, to administer programs focused on a wide array of health topics, including infectious diseases, chronic diseases, injury, disability, occupational health, environmental health, and public health emergency preparedness and response. Most of CDC's domestic programs fall within three main categories: (1) support to SLTT health agencies; (2) science and data; and (3) health education and guidance. The discussion below is not exhaustive of all CDC programs but is intended to provide an illustrative view of CDC programs and their scope.

CDC also provides assistance to international governments and organizations through its global health programs, which are not a focus of this report. For more information on CDC global health programs, see CRS In Focus IF11758, U.S. Global Health Funding: FY2020-FY2023 Appropriations.

Support to SLTT Public Health Agencies

Since CDC's inception, one of its primary functions has been to support public health agencies at the SLTT levels. CDC supports these agencies in all areas of public health through technical assistance, guidance, leadership, convenings, funding (primarily through grants, as discussed in the next section), and other material assistance. CDC staff can provide support during outbreaks and other emergencies, including by investigating and responding to threats. For example, through CDC's Epidemiologic Assistance program, SLTT public health agencies can request that EIS officers help investigate public health problems such as "infectious and noninfectious disease outbreaks, unexplained illnesses, or natural or manmade disasters."159 CDC also administers several fellowship and workforce programs to fund staff at SLTT agencies. CDC staff may also take temporary placement positions within SLTT agencies.

Major Grant and Assistance Programs

CDC administers numerous programs that provide funding or other assistance to SLTT health agencies. In FY2022, CDC obligated a total of $10.3 billion in financial assistance to states and territories. This total includes some direct funding to local governments or organizations within states and some American Rescue Plan Act and other supplemental funding.160 Of this total, $4.2 billion was spent on direct assistance through the Vaccines for Children program.

Resources for CDC Grants

CDC's grant funding profiles web page provides summaries of CDC grant funding by state: https://fundingprofiles.cdc.gov/.

HHS also makes available detailed grant data in its Tracking Accountability in Government Grants System (TAGGS). Users can explore HHS grant data by agency (operating division), state, recipient, activity type, and other criteria: https://taggs.hhs.gov/.

Available CDC grant opportunities are posted at grants.gov. See CDC, "Grants: How to Apply," https://cdc.gov/grants/applying/index.html.

Under this Medicaid-financed program, CDC purchases recommended childhood vaccines at a negotiated discounted rate and then distributes them to SLTT public health agencies to provide to eligible children (see the "Vaccines for Children" section).161

CDC also funds many grant programs that finance the public health programs of SLTT government agencies. Some grant programs, such as the Public Health Emergency Preparedness (PHEP) cooperative agreement program and the Preventive Health and Health Services Block Grant program, provide public health funding to all states, territories, and selected local jurisdictions. Others provide funding on a competitive basis to a subset of SLTT agencies. Most CDC grants are awarded to states or territories that are then responsible for distributing funds within their jurisdictions, although some CDC grants are awarded directly to local or tribal agencies. CDC administers many of its grant programs with SLTT agencies as cooperative agreement programs, where CDC staff have substantial involvement with the grantee in program implementation.

Table 2 summarizes the 10 largest CDC grant programs by funding amount in FY2022. These grant awards were funded by both regular and supplemental appropriations (especially American Rescue Plan Act appropriations). In many cases, CDC used appropriations from several different appropriations accounts and budget lines to fund a single program.

Table 2. Top 10 CDC Grant Programs, by Funding Amount in FY2022

Funded by regular and supplemental appropriations

Program Name and Description

2022 Recipients

Authorizationsa

FY2022 Funding (rounded)

Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Cooperative Agreement: Supports SLTT health department capacity to detect, prevent, and respond to infectious diseases. Grant programs consists of several components, including subprojects to specific jurisdictions focused on specific topics (e.g., parasitic diseases, mycotic diseases). A large portion of COVID-19 relief grant funding was awarded through this mechanism.

64 total: 50 states, eight territories and freely associated states (T/FAS), the District of Columbia (DC), and five cities (recipients vary by subaward within larger grant program).

General: PHSA §§301(a) and 317(k)(2) [42 U.S.C. §§241(a) and 247b(k)(2)]

ELC-specific: PHSA §2821 [42 U.S.C. §300hh-31]

Prevention and Public Health Fund: ACA §4002 [42 U.S.C. §300u–1]

$1.018 billion

Public Health Emergency Preparedness (PHEP) Cooperative Agreement: Strengthens public health preparedness and response capabilities of SLTT public health departments, including, for example, coordination of emergency response, distribution of medical countermeasures (e.g., vaccines), and sharing of emergency information.

62 total: 50 states, eight T/FAS, DC, and three cities.

PHSA §319C-1 [42 U.S.C. §247d-3a]

$649 million

Immunization Cooperative Agreements: Supports infrastructure for immunization programs, including vaccination clinic operations; education and awareness; vaccine storage and delivery systems; data systems; provider outreach and training; and some vaccine purchase for the uninsured and underinsured.

64 total: 50 states, eight T/FAS, DC, and five cities.

PHSA §317 [42 U.S.C. §247b] and SSA §1928 (Vaccines for Children program) [42 U.S.C. §1396s]

$462 million

Integrated HIV Surveillance and Prevention Programs for Health Departments: Supports comprehensive HIV surveillance and prevention programs aimed at preventing new infections and improving health outcomes for those with HIV. Funded activities can include HIV testing and case reporting; investigation of clusters and outbreaks; linkage to HIV care and services; and other prevention programs (e.g., condom distribution, education and awareness).

60 total: 50 states, DC, Puerto Rico, and the U.S. Virgin Islands, and seven local health departments.

PHSA §318 [42 U.S.C. §247c]

$378 million

Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health: Funds national organizations to provide capacity-building assistance to the U.S. public health system.

39 national organizations (mostly nonprofit organizations).

General: PHSA §§317(k)(2) and 307 [42 U.S.C. §§247b(k)(2) and 242l]

Prevention and Public Health Fund: ACA §4002 [42 U.S.C. §300u–1]

$375 million

Strengthening STD Prevention and Control for Health Departments: Supports sexually transmitted disease prevention and control activities, including screening, surveillance, outbreak response, linkage to care, and other prevention and control activities.

59 total: 50 states, DC, Puerto Rico, the U.S. Virgin Islands, and six local health departments.

PHSA §318 [42 U.S.C. §247c]

$298 million

Overdose Data to Action: Supports surveillance on fatal and nonfatal drug overdoses, along with activities to use data to inform outreach and prevention.

66 total: 48 states, DC, 15 localities, and two territories.

PHSA §311 [42 U.S.C. §243]

$251 million

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations: Funds several CDC cancer prevention and control programs, including (1) National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which supports breast and cervical cancer screenings and other clinical services for women who are uninsured or underinsured; (2) the National Comprehensive Cancer Control Program (NCCCP), which supports jurisdiction-based cancer programs in formulating and implementing jurisdiction-wide cancer plans; and (3) the National Program of Cancer Registries (NCPR), which funds and supports cancer registries that collect data on cancer cases.

NBCCEDP (71 total): 50 states, DC, seven T/FAS, and 13 tribes.

NBCCEDP; PHSA §§1501-1508 and 1510 [42 U.S.C. §§300k-300n-4 and 300n-5]

$214 million

 

NCCCP (66 total): 50 states, DC, eight T/FAS, and seven tribes.

NCCCP: PHSA §317 [42 U.S.C. §247b]

 
 

NCPR: 47 states, DC, and three T/FAS.

NPCR: PHSA §§399B-399F(a) [42 U.S.C. §§280e-280e-4(a)]

 

Preventive Health and Health Services Block Grant: Block grant program allows jurisdictions to use flexible funding to meet their own unique public health needs and challenges. Some block grant funding is reserved for rape prevention and education activities.

61 total: 50 states, DC, eight T/FAS, and two tribes.

PHSA Title XIX, part A [42 U.S.C. Chapter 6A, Subchapter XVII, Part A]

$146 million

Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States: Funds mostly local jurisdictions as a part of the Ending the HIV Epidemic initiative. The grants are meant to complement other CDC HIV grants and specifically support increased testing, linkage to HIV treatment, and prevention, such as facilitating pre-exposure prophylaxis treatment in local areas that account for more than half of new HIV diagnoses.

57 total: 48 counties, DC, San Juan, Puerto Rico, and seven states.

PHSA §318 [42 U.S.C. §247c]

$120 million

Source: Funding data from CDC, "Grant Funding Profiles," https://fundingprofiles.cdc.gov/. Other table information from cdc.gov web pages and from grants.gov.

a. For consistency, CRS excluded appropriations laws when cited as a statutory basis for a particular program (not all source materials cited appropriations consistently).

Public Health Workforce

CDC offers a variety of internships, fellowships, and training opportunities for students and professionals in public health. Programs include fellowships for public health laboratory professionals, epidemiologists, informaticians, and other public health disciplines. These fellows often serve in SLTT health departments and other public health organizations. Prominent CDC fellowship and workforce programs include the EIS and CDC's Public Health Associate Program.162

CDC program grants are also commonly used to pay for SLTT public health staffing and workforce development. The American Rescue Plan Act of 2021 (ARPA)163 provided $7.7 billion for public health workforce programs.164 HHS allocated these funds for many purposes, including to support several new and existing CDC programs.165 CDC used a large portion of this funding, combined with regular appropriations, to fund a new Public Health Infrastructure Grant program in FY2023. Through this program, CDC awarded $3.7 billion to 107 health departments in all 50 states, Washington, DC, eight territories and freely associated states, and 48 large localities.166 Recipients are to use this award to hire and retain public health staff, strengthen organization systems and processes, and modernize public health data systems.167 State health department recipients are expected to distribute a portion of grant funds for public health workforce among local health departments that did not receive direct grant funding from CDC.168 Given this five-year grant is funded by a one-time appropriation from the ARPA, funds may no longer be available to support hired staff at the end of the five-year period.

CDC and the U.S. Public Health System

In the U.S. federalist system of government, SLTT governments are often at the forefront of public health. One of CDC's primary functions is to support the U.S. public health system at the SLTT level. State law provides the basis for many public health authorities in the United States, such as authorities to require quarantine and isolation or to mandate reporting of certain disease cases. Many public health programs are based at the local level, including, for example, vaccination programs and programs to inspect the health and safety of food service establishments. Over the course of the 20th and 21st centuries, the scope of SLTT public health agencies evolved similarly to how CDC evolved (sometimes as funded by CDC grants). U.S. jurisdictions vary considerably in how public health functions are organized among state and local governments, as do the scope of their public health activities.

Today, all states (including territories and DC) have a state health agency led by a state health official. All state health agencies engage in public health activities, some through a freestanding public health agency and others as a part of a combined health and human services agency. In addition, as of 2019, there were approximately 2,800 local health departments in the United States. U.S. public health agencies vary in terms of their governance structures. Some states have a centralized public health system, where the state government has primary authority and responsibility for public health throughout the state. The majority of states have a decentralized public health system, where local governments have primary authority and responsibility for public health (but are often still responsible for implementing state laws). Other states have mixed or shared governance arrangements for public health, where state and local governments share responsibility and authority in public health. In many cases, CDC has a primary funding and programmatic relationship with state health agencies. Local agencies can receive pass-through CDC grant funding from their states.

State and local public health agencies vary considerably in the scope of their activities. Virtually all state public health agencies engage in population health activities such as infectious disease control, public health emergency preparedness and response, epidemiology, surveillance, and prevention programs. Some state and local health agencies have a significant health care safety net mission, and therefore they have a large focus on supporting health care services for uninsured and underinsured populations. In other states, the health department may rely other types of providers to provide safety net services, such as community health centers. State and local jurisdictions also vary in terms of their priorities, especially the types of health problems that public health agencies are funded and empowered to address.

Sources: CDC, "Health Department Governance," https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html; Association of State and Territorial Health Officials (ASTHO), "State Health Agency Activities: Why Agencies May Not Provide the Same Services," 2019, https://www.astho.org/globalassets/pdf/state-health-agency-activities-why-agencies-may-not-provide-the-same-services.pdf; and National Association of County and City Health Officials (NACCHO), "National Profile of Local Health Departments: 2019," https://www.naccho.org/uploads/downloadable-resources/Programs/Public-Health-Infrastructure/NACCHO_2019_Profile_final.pdf.

Science and Data

CDC supports research and investigation into health challenges, generally with a focus on how they can be prevented and controlled. CDC research explores the distribution and prevalence of health problems and contributing risk factors within populations. CDC research also commonly evaluates the potential interventions to address those risk factors. CDC researchers and scientists come from diverse disciplines, including, for example, epidemiology, veterinary science, microbiology, engineering, economics, social and behavioral sciences, and statistics.169 Many CDC research articles are published in the agency's Morbidity and Mortality Weekly Report. CDC also awards some research grants and contracts to universities and other research institutions.

In addition, CDC supports laboratory science to aid with detecting and investigating infectious diseases and other health threats. CDC manages federal laboratories that can perform specialized testing to detect new or unusual diseases. CDC also plays a significant role in informing the practices and capacities of the nation's network of public health laboratories. This includes CDC's role in overseeing the Laboratory Response Network (LRN)—a network of laboratories at the federal, state, and local levels that can detect biological, chemical, and other threats, including emerging infectious diseases. (Not all public health laboratories are LRN laboratories.) CDC develops laboratory test kits, protocols, and best practices, and it distributes test kits and supplies to LRN and other public health laboratories. Several grant programs can also support public health laboratory operations and testing.170

To facilitate public health research and science, CDC has many programs for collecting and analyzing health data. CDC uses the data in its own research and makes data available to outside researchers and sometimes the general public. CDC's data collection programs generally fall into two categories: surveillance systems and surveys.

Surveillance Systems

Public health surveillance is "the ongoing, systematic collection, analysis, and interpretation of health-related data essential to planning, implementation, and evaluation of public health practice." CDC operates over 100 surveillance systems that collect data on an ongoing basis.171 Table 3 provides an illustrative summary of selected CDC surveillance systems. CDC often receives its data from SLTT health departments, mostly on a voluntary basis through data-sharing agreements with those agencies.172 SLTT health agencies generally collect public health data based on their own legal requirements and policies.173 Many CDC grants support SLTT surveillance activities. The data CDC receives, which typically do not include personally identifiable information, help inform an understanding of when, how, where, and to whom disease cases and other health events occur at a population level.

Table 3. Selected CDC Surveillance Systems

Surveillance System

Statutory Authorizations

Type of Primary Data

Reporting Mechanism

Purpose

National Notifiable Diseases Surveillance System

Public Health Service Act (PHSA) Section 301 [42 U.S.C. §241]

Nationally notifiable disease cases (infectious and noninfectious conditions) reported using a standardized case definition.

SLTT health departments report de-identified cases to CDC.

(Laboratories and health care providers report to health departments pursuant to state reporting laws.)

System allows for monitoring and control of certain infectious and some noninfectious diseases and conditions. Data include demographic, health information, and exposure history for confirmed cases.

National Syndromic Surveillance Program

PHSA Section 319D [42 U.S.C. §247b]

Algorithms analyze de-identified electronic health record data on patient symptoms and other health indicators to monitor health trends (does not require reporting of specific cases).

Systems operated by state and local health departments, as well as the Department of Defense (DOD) and the Department of Veterans Affairs (VA), that report to CDC using BioSense platform.

(Data provided from outpatient health care providers in all 50 states, Puerto Rico, the District of Columbia, and the U.S. Virgin Islands.)

System allows for real-time monitoring and control of a variety of diseases and conditions.

Currently used for diverse purposes, including responses to the COVID-19 pandemic, influenza, drug overdoses, suicide, health effects of natural disasters, and foodborne illness outbreaks, among others.

National Vital Statistics System

PHSA Section 306 [42 U.S.C. §242k]

Records of deaths, births, and fetal deaths.

SLTT vital records offices report to CDC.

Records include information that is used in national health statistics. For example, death records include information on underlying cause of death and contributing causes of death.

National Violent Death Reporting System

PHSA Section 301 [42 U.S.C. §241] and PHSA Section 392(a)(1) [42 U.S.C. §280b-0(a)(1)]

Data on violent deaths, including type of death (i.e., homicide, suicide), method, relationship between perpetrator and victim, demographic information, and more.

State-based programs compile data based on death certificates, law enforcement records, and medical examiner/coroner reports for submission to CDC's database.

Data help provide greater understanding of violent deaths and the circumstances surrounding them in order to inform prevention and research at national, state, and local levels.

Behavioral Risk Factor Surveillance System

PHSA Section 301 [42 U.S.C. §241]

Survey data on health-related risk behaviors, chronic health conditions, use of preventive health services, and other health issues.

States administer BFRSS survey collection from households in accordance with program guidelines.

All states administer core questionnaire annually. Certain survey modules are optional. States use data to inform their public health planning. National data measures progress against national health goals (Healthy People) and used for research.

National Respiratory and Enteric Virus Surveillance System

PHSA Section 301 [42 U.S.C. §241]

Data on testing for viruses, including coronaviruses, rotavirus, norovirus, respiratory syncytial virus (RSV), and others.

Participating laboratories, including clinical and public health laboratories, voluntarily share data.

System helps monitor the spread of viruses and types circulating.

National Program of Cancer Registries

PHSA Section 301 [42 U.S.C. §241] and Part M of PHSA Title III [42 U.S.C. §280e et. seq.]

Cancer registry data include information on patient demographics, occupational history, health history, cancer type, treatment(s) received, and patient outcomes, among other information.

Health department cancer registries report de-identified data to CDC.

(Health care facility cancer registrars report data to health department-run cancer registries.)

Cancer registry data allows for monitoring cancer trends and informing research about cancer, including its cause, prevention, and appropriate treatment.

Source: CRS analysis based on CDC websites and grant guidance documents, the Office of Management and Budget's Information Collection Review, Federal Register notices, and other public health literature and policy publications.

Health Surveys

CDC also administers many surveys, including national population health surveys such as the National Health Interview Survey and surveys of health care providers. CDC's National Center for Health Statistics is one of 13 principal federal statistical agencies (or units).174

In a population-based health survey, respondents (or a knowledgeable proxy) report information about themselves or about all the people in a household.175 Population-based surveys can include biological samples for testing, such as blood samples. There is overlap between surveillance systems and surveys. Some surveillance systems involve population-based surveys (e.g., BRFSS). However, not all CDC health surveys are considered surveillance systems.

Table 4. Selected CDC Surveys

Survey

CDC CIO

Design

Summary

National Health Interview Survey

National Center for Health Statistics

Household interview survey. Nationally representative sample.

Survey provides the "[p]rincipal source of information on the health of the civilian noninstitutionalized population of the United States." Includes questions on a broad range of health topics along with demographic and socioeconomic characteristics of the respondents.

National Health and Nutrition Examination Survey

National Center for Health Statistics

Survey on adults and children that includes interviews and physical examinations and clinical tests. Nationally representative sample.

Survey assesses chronic and other conditions, health behaviors, risk factors, and demographic characteristics. Physical examinations include body measurements, blood samples, and dental screenings, along with other tests and procedures depending on interviewee characteristics (e.g., sex and age).

National Survey of Family Growth

National Center for Health Statistics

Interview-based survey of adult women and men (aged 15-49). Nationally representative sample.

Survey gathers information on pregnancy, births, marriage and cohabitation, and reproductive health.

National Post-Acute and Long-Term Care Study

National Center for Health Statistics

Mail, web, and telephone surveys of directors of adult day care and residential care facilities, along with administrative data.

Survey assesses geographic and operating characteristics, services, practices, and staffing. Also includes characteristics of population served.

Behavioral Risk Factor Surveillance System

National Center for Chronic Disease Prevention and Health Promotion

Telephone-based, state-administered survey. All 50 states, DC and three territories participate.

Survey collects information on health-related risk behaviors, chronic health conditions, use of preventive health services, and other health issues.

National Youth Tobacco Survey

National Center for Chronic Disease Prevention and Health Promotion

School-based survey of middle and high school students. Nationally representative sample.

Survey includes measures on tobacco-related behaviors, attitudes, beliefs, and exposure to related influences.

Youth Risk Behavior Surveillance System

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

CDC- and SLTT-administered, school-based survey of high school students. Nationally representative sample.

Survey collects information on, among other topics, health risk behaviors, including tobacco use; dietary behaviors; physical activity; alcohol and other drug use; sexual behaviors; and violence-related behaviors, along with demographic information on students.

Pregnancy Risk Assessment Monitoring System

National Center for Chronic Disease Prevention and Health Promotion

Participating SLTT agencies conduct a mail- and telephone-based survey of women who have had a recent live birth (according to birth certificate files). Currently, 46 states, DC, New York City, Northern Mariana Islands, and Puerto Rico participate.

Survey asks new mothers about their behaviors and experiences before, during, and after pregnancy, as well as the health of their infant.

Source: CRS analysis based on CDC and HHS websites, the Office of Management and Budget's Information Collection Review, Federal Register notices, and other public health literature and policy publications.

Health Education and Guidance

CDC conducts education and outreach to many audiences, including the general public, clinicians, and public health practitioners, among others. For example, through its Health Alert Network (HAN), CDC can rapidly share information about urgent public health threats with public information officers, federal and SLTT public health practitioners, and clinicians and public health laboratories.176 CDC has used the HAN system to issue alerts about diverse health issues, including, but not limited to, rising fentanyl deaths, emerging infectious diseases, recommended health care sanitation procedures, medical product shortages (and associated clinical practice recommendations), and the health effects of natural disasters.177

CDC also regularly develops educational materials for SLTT agencies, health care providers, and the general public. Health education is a component of almost all of CDC's programs related to specific diseases and health issues.178 CDC informs the science and practice of public health communication as a part of its mission as well.179

In addition, CDC develops public health and clinical guidelines based on its expertise in health science and practice. As official recommendations, CDC guidelines are generally not legally binding. Some of CDC's guidelines play a significant role in federal health policy. For example, CDC's Advisory Committee on Immunization Practices (ACIP), made up of nonfederal experts and representatives, makes guidelines and recommendations regarding the use of vaccines and related agents. Based on these recommendations, CDC develops the child and adult immunization schedules of routinely recommended vaccines. ACIP recommendations also inform which vaccines are provided through the Vaccines for Children program (see the "Vaccines for Children" section). ACIP's recommendations also serve as the basis for several statutory health care coverage requirements for vaccines, including for private health insurance, Medicaid, Medicare Part D, and the State Children's Health Insurance Program.180

CDC also develops and disseminates information on public health and clinical best practices, for example, for youth violence prevention programs or for health care provider conversations about vaccines with patients.181

Regulations

CDC is not primarily a regulatory agency. Administering and enforcing regulations is not a main activity for the agency. As discussed below, however, CDC administers regulations in a few areas:

Quarantinable Communicable Diseases

The below list of quarantinable communicable diseases is established by Executive Order (E.O.) 13295:

  • Cholera
  • Diphtheria
  • Infectious tuberculosis
  • Plague
  • Smallpox
  • Yellow fever
  • Viral hemorrhagic fevers
  • Severe acute respiratory syndromes
  • Flu that can cause a pandemic
  • Measles

This E.O. was first established by President Bush in 2003 and then amended in 2005 (E.O. 13375), in 2014 (E.O. 13674), and in 2021 (E.O. 14047).

Medical examination of immigrants and refugees. In 42 C.F.R. Part 34, CDC has developed the medical examination and vaccination requirements for noncitizens seeking to enter the United States as immigrants or refugees. These regulations are based on provisions of the PHSA and the Immigration and Nationality Act.

Interstate and foreign quarantine of people. PHSA Sections 361 through 369 grant the HHS Secretary certain authorities to control the spread of communicable diseases, including through federal quarantine and inspection. Based on these provisions, CDC administers separate regulations for interstate and foreign quarantine in 42 C.F.R. Parts 70 and 71, respectively.182 These regulations, for instance, specify the conditions under which the CDC Director may authorize the apprehension, medical examination, quarantine, or isolation of an individual with or exposed to certain communicable diseases—known as quarantinable communicable diseases—who is traveling into the United States or between states.183 Quarantinable communicable diseases are established by executive order, as explained in the text box above. The regulations also authorize CDC to take action in the event that state or local control of a communicable disease is deemed inadequate to prevent its spread. Such actions may include "measures to prevent such spread of the diseases as [the CDC Director] deems reasonably necessary, including inspection, fumigation, disinfection, sanitation, pest extermination, and destruction of animals or articles believed to be sources of infection."184

Importation of human remains, certain animals, and infectious biological materials. CDC administers several regulations aimed at preventing and controlling the spread of infectious diseases from imported materials, including from human remains, certain animals, and infectious biological materials.185 These regulations are all part of 42 C.F.R. Part 71, the foreign quarantine regulations mentioned above.

Federal Select Agent Program. CDC, along with the U.S. Department of Agriculture, administers the Federal Select Agent Program (FSAP), which regulates the possession, use, and transfer of select biological agents and toxins that have potential to pose a public health threat.186As part of the FSAP, CDC publishes and updates a list of select agents and toxins regulated under the program. Regulated entities are typically laboratories that use these select agents in research. The statutory authorization for the program was established in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002.187

Occupational Safety and Health Regulations. CDC's NIOSH administers several regulations related to occupational health. For example, 42 C.F.R. Part 37 requires coal mine operators to provide medical examinations to coal miners, as authorized in the Federal Mine Safety and Health Act of 1977.188 As another example, NIOSH regulates respiratory protective devices, such as N95 respirators, in 42 C.F.R. Part 84.189

Health Services Programs

CDC administers two large health services programs funded by mandatory budget authorities: the Vaccines for Children program and the World Trade Center Health Program.

Vaccines for Children

The Vaccines for Children (VFC) program is a Medicaid-financed and CDC-administered program to provide recommended childhood vaccines at no cost to eligible children.190 The Advisory Committee on Immunization Practices determines the list of VFC vaccines through VFC-ACIP Vaccine Resolutions.191

Through VFC, CDC purchases recommended childhood vaccines at a federally negotiated discounted rate. These vaccines are then distributed to SLTT health agencies to further distribute to participating providers.192 CDC also provides a portion of VFC funding to states for program administration through the Immunization Cooperative Agreement program (in addition to discretionary funding), a grant program that supports state immunization programs.193

Children eligible to receive VFC vaccines include those who are (1) Medicaid eligible; (2) not insured; (3) without adequate insurance and who are receiving a vaccine at a federally qualified health center or a rural health clinic; and (4) American Indian or Alaska Native.194 Participating providers cannot charge patients for the cost of VFC vaccines. Providers may charge patients a fee for vaccine administration as determined by the HHS Secretary, but they cannot deny a vaccine due to inability to pay the fee.195

Like other Medicaid programs, VFC is an appropriated entitlement program, meaning that funds are provided through annual appropriations but actual program spending is based on need and eligibility. In FY2022, the VFC program spent a total of $5.54 billion.196

World Trade Center Health Program197

The World Trade Center Health Program (WTCHP), administered by NIOSH, provides medical monitoring and treatment for certain conditions related to health exposures from the September 11, 2001, terrorist attacks in New York City, at the Pentagon, and in Shanksville, PA. The program currently serves over 110,000 responders and survivors from the attacks. In addition, the program supports some medical research related to 9/11 health exposures.198

To be covered by the program, individuals must meet eligibility criteria and be certified as having a covered condition related to 9/11 exposure. Current categories of covered conditions include (1) acute traumatic injuries, (2) airway and digestive disorders, (3) cancers, (4) mental health conditions, and (5) musculoskeletal disorders (WTC responders only).199 Members must receive WTCHP services through several Clinical Centers of Excellence in New York or through a nationwide provider network of certified clinics.200

WTCHP was authorized in 2011 through the James Zadroga 9/11 Health and Compensation Act201 (Zadroga Act) which replaced a preexisting similar program funded by discretionary appropriations.202 The Zadroga Act added a new PHSA Title XXXIII, which established a WTCHP Fund that provides annual capped mandatory appropriations for the program. In addition, the City of New York is required to contribute 10% of the annual costs of the program. Since FY2017, annual obligations for program expenses have exceeded the annual appropriated amounts under PHSA XXXIII.203 CDC has used carryover funding to cover the difference, and Congress provided an additional supplement funds through laws enacted in 2022 and 2023.204 In FY2022, CDC spent $641.5 million on the program.205

Considerations and Options for Reform

Following the COVID-19 pandemic, several stakeholders and Members of Congress have called for CDC reform.206 Some Members in both House and Senate committees of jurisdiction have sought stakeholder feedback on potential CDC reform.207

Defining the Mission

A central question before Congress regarding CDC reform is this: what is the appropriate mission and scope of the agency? Congress most recently defined the scope of the CDC Director's responsibilities in statute as relating to "the investigation, detection, identification, prevention, or control of diseases or conditions to preserve and improve public health domestically and globally and address injuries and occupational and environmental hazards, as appropriate."208

Scoping CDC by Disease and Health Area

There is debate within and outside of Congress on the scope of health topics for CDC. Some have argued that CDC should return to its founding mission and focus on communicable diseases.209 Representative Miller-Meeks stated in a hearing,

The CDC is supposed to be the nation's leading science based communicable diseases agency, not preventable medical diseases or climate change, although those things are very important, with public health being the number one goal, especially as related to communicable diseases.210

As recounted in this report, CDC evolved as public health scientists and experts learned to apply the methods developed for communicable disease prevention and control to a wide array of health challenges and threats. Some have argued that CDC's work across diseases and health areas has helped the agency address interrelated health issues.211 For example, as stated by the Infectious Diseases Society of America and the HIV Medicine Association,212

[W]e recognize the role of noncommunicable diseases in exacerbating the consequences of communicable diseases. We support continued efforts by CDC to address chronic diseases, environmental health and other health threats that negatively impact the ability of individuals to remain healthy during and after exposure to an infectious agent and to recover quickly from illness if they become sick.

Since CDC's founding, the public health field has moved beyond a sole focus on communicable diseases globally. Public health now encompasses efforts to address a wide array of preventable health challenges and to promote health more generally. Yet the broad definitions of public health may raise the question: what health issues and underlying contributors do not fit within CDC's scope?

Scoping CDC by Function

When viewed in terms of functions instead of disease areas or health topics, CDC's scope appears narrower. Across almost all diseases and health areas, CDC's domestic programs generally engage in a core set of activities, as illustrated in the "Activities" section of this report: (1) support to SLTT health agencies, (2) science and data, and (3) health education and guidance.

Some of CDC's programs serve cross-cutting purposes across disease areas. For example, CDC's Health Alert Network is used to alert providers and other health professionals about a wide array of threats and topics: rising fentanyl deaths, emerging infectious diseases, recommended health care sanitation procedures, medical product shortages (and associated clinical practice recommendations), and the health effects of natural disasters.213 As another example, CDC's National Syndromic Surveillance System, which was originally developed for monitoring bioterrorism threats at emergency departments, is now used for monitoring diverse health threats and topics, including COVID-19, influenza, drug overdoses, suicide, health effects of natural disasters, and foodborne illness outbreaks, among others (see Table 3).214 CDC's Moving Forward structural review recommended that the agency "support, elevate and empower" cross-cutting functions and core capabilities within the agency.215 Thus, CDC itself may seek to further expand programs that crosscut disease or health areas. If Congress is to change or limit the scope of CDC's mission, it may face challenges and questions around how to deal with cross-functional programs, and whether changing the agency's mission would enhance or diminish CDC's work.

Scoping CDC by Role

CDC can also be viewed in terms of the roles it plays. CDC plays a role in preparedness and response to emerging health threats (e.g., epidemics, bioterrorism), but it also supports ongoing disease prevention and health promotion activities. In some cases, these roles are complementary. For example, CDC leveraged its infrastructure for distributing routine vaccines to distribute COVID-19 vaccines during the pandemic on an emergency basis.216 As a part of its Moving Forward initiative, CDC is working to become a more response-oriented agency overall, including by expanding emergency response trained staff and functions across the agency.217

Other countries have chosen to designate public health prevention and health security functions to separate agencies. For example, during the COVID-19 pandemic in April 2021, the United Kingdom disbanded Public Health England and created a new UK Health Security Agency for health protection capabilities (e.g., pandemic preparedness and response) and transferred existing health improvement, prevention, and other public health functions to other agencies and offices.218 Congress could seek further information on the outcomes of the United Kingdom's and other countries' public health agency reforms and structures, and whether any lessons learned could have implications for the United States' federal public health agencies. In the United States, health security functions are currently divided among different HHS agencies.219 For example, the Administration for Strategic Preparedness and Response is authorized in statute to coordinate federal public health and medical preparedness for and response to emergencies.220

Selected Policy Options

Stakeholders and some Members of Congress have proposed policy options for CDC reform discussed in the next sections. These options are not mutually exclusive; Congress could choose to pursue none or all of the options.

Await Results from the Moving Forward Initiative

Some argue that Congress should allow CDC to continue with its own internal reform efforts through the Moving Forward initiative before considering any further legislative reform. Dr. Georges Benjamin, Executive Director of the American Public Health Association, stated at a House hearing with regard to the Moving Forward initiative,

We are supportive of the agency's efforts to address these concerns and believe that Congress should allow the agency the appropriate amount of time to implement these significant changes to its structure and programs. At this time, we do not believe any additional major restructuring is needed to overhaul the agency's structure or programs.221

Some groups argue against further CDC legislative reform. The CEO of the Association of State and Territorial Health Officials (ASTHO) stated, "It is ASTHO's opinion that CDC's mission and purpose are clear to the field and there is no need to authorize the agency further."222

If it chooses to maintain the status quo, Congress might consider how to conduct oversight of the agency's ongoing reform efforts. Congress may consider how to evaluate CDC's reforms and determine if and when they have met their intended objectives. Congress might also consider whether to provide CDC with any of the authorities that the agency has requested as a part of the Moving Forward initiative, such as data and workforce authority.223

Establish a CDC Reform Process

Several stakeholders have called for Congress to establish a process for considering CDC reform. One independent evaluation, led by the Center for Strategic and International Studies (CSIS), called for "a high-level executive-congressional dialogue on CDC's future." According to the report, the dialogue should involve senior leaders in the White House, HHS, CDC, and Congress to discuss additional reform actions beyond the Moving Forward initiative. The report also proposes establishing an external advisory group to inform long-term reform efforts.224 Others have recommended similar external review processes by a congressionally established commission to inform CDC reform.225 Different stakeholders have argued that any review process should include a whole-of-government evaluation of the federal response to COVID-19 inclusive of all agencies and departments, rather than a sole focus on CDC.226

If it establishes a CDC reform process, Congress faces choices around how to structure such a process. For example, if it establishes an external advisory committee, Congress may consider who should serve on such committee, what areas of expertise should be represented, and how committee members are to be selected. Congress might also wish to direct the committee in how to evaluate CDC to inform its recommendations. Congress might also consider whether to establish a process for formally weighing the committee's recommendations and whether to adopt them in legislation.

Further Authorize CDC

Several stakeholders have called on Congress to formally authorize or codify CDC as an agency.227 One health policy research center has argued, "Congress should engage in the hard work of outlining exactly what activities the CDC should and should not undertake."228

CDC is not the only agency within the federal government that lacks an organic or enabling statute established by Congress. Other examples include the Bureau of Safety and Environmental Enforcement in the Department of the Interior and the Health Resources and Services Administration within HHS.229 According to one analysis by political science scholars, 40% of federal agencies established from 1946 through 1995 were established by executive action rather than legislation.230

Congress may seek to clarify its policy goals if pursuing CDC formal authorization. Some argue that such authorization would address perceived "mission creep" of the agency and its activities. In particular, some argue that CDC's expanded scope across a wide range of disease areas affected its preparedness and response to communicable disease emergencies such as the COVID-19 pandemic.231 Thus Congress might consider how to appropriately define CDC's mission and scope, as discussed in the "Defining the Mission" section. Congress might also contemplate the powers and capabilities it wishes CDC to have in fulfilling its mission.

In addition, Congress faces choices about the degree of specificity in authorizing CDC and its programs. As summarized in this report, many CDC programs cite general authorities in the PHSA as their statutory basis. This structure has arguably afforded CDC some flexibility to respond to diverse health challenges. For example, in the past few years, CDC has responded to infectious disease outbreaks such as the COVID-19 pandemic and mpox, lung injury associated with electronic vaping devices, rising opioid overdoses and deaths, and the health effects associated with natural disasters.232 At the same time, formal congressional authorization may provide more explicit direction and perhaps accountability for CDC programs. Congress might consider whether formal authorization will help CDC overcome the issues and challenges faced during the pandemic.

Congress faces many choices in terms of what formal CDC authorization could look like. Congress could choose a flexible authorization, one that would further define CDC's mission and responsibilities but leave specifics of CDC's structure and programs to the agency or HHS. On the other end of the spectrum, Congress could formally authorize and delineate the agency's overall structure and each of its specific programs and activities. As noted in this report, CDC is currently authorized by a mix of general and specific program authorities. Congress could seek to review CDC's existing statutory authorizations, as well as its current programs and activities, to determine the appropriate legislative path forward for the agency.


Senior Research Librarian Ada Cornell provided valuable research assistance for this report. Visual Information Specialists Juan Pablo Madrid and Jamie Hutchinson provided graphics assistance for this report. Specialist in American National Government Henry Hogue assisted with research on the history of CDC reorganizations.

Footnotes

1.

See Brief History section of this report.

2.

See CDC's Evolution in Context section of this report.

3.

See, for example, Rep. Mariannette Miller-Meeks, "Miller-Meeks Seeks Stakeholder Feedback to Reform CDC Following Years of Consistent Failures and Broken Trust," press release, April 5, 2023, https://millermeeks.house.gov/media/press-releases/miller-meeks-seeks-stakeholder-feedback-reform-cdc-following-years-consistent.

4.

See, for example, HHS Office of the Inspector General, CDC's Internal Control Weaknesses Led to Its Initial COVID-19 Test Kit Failure But CDC Ultimately Created a Working Test Kit, A-04-20-02027, October 2023, https://oig.hhs.gov/oas/reports/region4/42002027.pdf; and U.S. Congress, House Committee on Oversight and Accountability, Oversight of CDC Policies and Decisions During the COVID-19 Pandemic, 118th Cong., 1st sess., June 7, 2023.

5.

J. Stephen Morrison and Tom Inglesby, Building the CDC the Country Needs, Center for Strategic and International Studies, January 2023, https://csis-website-prod.s3.amazonaws.com/s3fs-public/publication/230112_Morrison_Building_CDC.pdf?VersionId=kTKB3urWn1bfZpXuCqixfxzHfT8AUcIM.

6.

The COVID Crisis Group, Lessons from the COVID War: An Investigative Report (New York, NY: PublicAffairs, 2023), pp. 64, 166.

7.

CDC, "CDC Moving Forward Summary Report," September 2022, https://www.cdc.gov/about/organization/cdc-moving-forward-summary-report.html.

8.

Dr. Joel M. Zinberg and Drew Keyes, Unauthorized and Unprepared: Refocusing the CDC After COVID-19, Paragon Health Institute, July 2023, https://paragoninstitute.org/wp-content/uploads/2023/07/Unauthorized-and-Unprepared-Refocusing-the-CDC-after-COVID-19_Zinberg-Keyes_FOR-RELEASE_V1.pdf and Letter from Academy of General Dentistry (to The Honorable Mariannette Miller-Meeks, MD, Representative, House Committee on Energy and Commerce, April 23, 2023, https://www.agd.org/docs/default-source/advocacy-papers/agd-miller-meeks-letterhead-cdc-rfi_.pdf?sfvrsn=1904d33c_0.

9.

U.S. Congress, House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, Looking Back Before Moving Forward: Assessing CDC's Failures in Fulfilling its Mission, 118th Cong., 1st sess., June 7, 2023.

10.

J. Stephen Morrison and Tom Inglesby, Building the CDC the Country Needs, Center for Strategic and International Studies, January 2023, https://csis-website-prod.s3.amazonaws.com/s3fs-public/publication/230112_Morrison_Building_CDC.pdf?VersionId=kTKB3urWn1bfZpXuCqixfxzHfT8AUcIM and Brian J. Miller, Niraj Gowda, and Padmini Ranasinghe, et al., "A Vision for Supporting and Reforming The CDC," Health Affairs, June 10, 2022.

11.

American Public Health Association, Testimony of Georges C. Benjamin, Executive Director at Looking Back Before Moving Forward: Assessing CDC's Failures in Fulfilling its Mission, House Energy and Commerce Committee, Subcommittee on Oversight and Investigations, June 7, 2023, p. 32 and Letter from Michael R. Fraser, CEO, Association of State and Territorial Health Officials to Sen. Bill Cassidy, ranking member, Senate Committee on Health, Education, Labor, and Pensions, October 20, 2023, https://www.astho.org/globalassets/pdf/government-affairs/astho-responds-to-senate-help-rfi-on-cdc-reform-october-2023.pdf.

12.

42 U.S.C. §§9601 et seq., at §9604(i)

13.

Institute of Medicine, Chapter 3: A History of the Public Health System, The Future of Public Health., 1988, https://www.ncbi.nlm.nih.gov/books/NBK218224/; and Bernard J. Turnock, "Chapter 1: What is Public Health?" in Public Health: What it is and How it Works, 5th ed. (Jones and Bartlett Learning, LLC, 2012), p. 5.

14.

Bernard J. Turnock, "Chapter 1: What is Public Health?" in Public Health: What it is and How it Works, 5th ed. (Jones and Bartlett Learning, LLC, 2012), p. 6.

15.

Institute of Medicine, Chapter 3: A History of the Public Health System, The Future of Public Health., 1988, https://www.ncbi.nlm.nih.gov/books/NBK218224/.

16.

"An Act for the Relief of Disabled Seamen," 5th Cong., https://memory.loc.gov/cgi-bin/ampage?collId=llsl&fileName=001/llsl001.db&recNum=728, and National Library of Medicine (NLM), "History of the Public Health Service: Disease Control and Prevention- Health Care for Seamen," https://www.nlm.nih.gov/exhibition/phs_history/seamen.html.

17.

National Quarantine Act of 1878, P.L. 45-66. See Centers for Disease Control and Prevention (CDC), "History of Quarantine (Port Health)," https://www.cdc.gov/quarantine/historyquarantine.html.

18.

National Library of Medicine, "History of the Public Health Service: Disease Control and Prevention- Fighting the Epidemic Spread of Disease," https://www.nlm.nih.gov/exhibition/phs_history/seamen.html.

19.

National Library of Medicine, "History of the Public Health Service: Two Centuries of Health Promotion," https://www.nlm.nih.gov/exhibition/phs_history/seamen.html, and CDC, "The Roots of Public Health and CDC," https://www.cdc.gov/museum/online/story-of-cdc/roots/index.html.

20.

P.L. 78-184.

21.

The Federal Security Agency was established by Reorganization Plan No. 1 of 1939. In addition to the U.S. Public Health Service, it included as subunits the Social Security Board, the U.S. Employment Service, the Office of Education, and other public welfare-related entities. The Federal Security Agency later became the Department of Health, Education, and Welfare, which in turn became the Department of Health and Human Services.

22.

Alanson W. Willcox, "The Public Health Service Act, 1944," Public Health Service, Federal Security Agency Bulletin, August 1944.

23.

Alanson W. Willcox, "The Public Health Service Act, 1944," Public Health Service, Federal Security Agency Bulletin, August 1944.

24.

CDC, "Our History-Our Story," https://www.cdc.gov/museum/history/our-story.html. In a 1946 supplement to the Code of Federal Regulations, CDC was listed as a field station of the States Relations Division within the Bureau of State Services of the U.S. Public Health Service. (U.S. National Archives, Division of the Federal Register, 1946 Supplement to the Code of Federal Regulations of the United States of America [Washington: GPO, 1947], p. 6149-6153.)

25.

Federal Security Agency, U.S. Public Health Service, Development of the Communicable Disease Center, 1946, https://globalhealthchronicles.org/files/original/151a6159652008b3bf2ce2f158a5cdc1.pdf.

26.

Federal Security Agency, U.S. Public Health Service, Development of the Communicable Disease Center, 1946, https://globalhealthchronicles.org/files/original/151a6159652008b3bf2ce2f158a5cdc1.pdf; Helen Neff, "The Center for Disease Control—1946-1976," Connecticut Medicine, 1979; and William Foege, "Centers for Disease Control," Journal of Public Health Policy, 1981.

27.

Elizabeth W. Etheridge, "Chapter 1: War and the Mosquito," in Sentinel for Health: A History of the Centers for Disease Control and Prevention (University of California Press, 1992), pp. 16-17. According to the book, "the U.S. Public Health Service had all the authority it needed to set up the new center, however, it needed funding from Congress." FY1946 appropriations (P.L. 79-124) for the Public Health Service included a new line item for "communicable diseases" with a funding level of $1.04 million (the FY1945 appropriations law [P.L. 78-373] did not include a similar line item.) For examples of discussions of related appropriations, see U.S. Congress, House Committee on Appropriations, Subcommittee on Labor Department and Federal Security Appropriations, Department of LaborFederal Security Agency Appropriation Bill for 1946, hearings, 79th Cong., 1st sess., April 19, 1945 (Washington: GPO, 1945), pp. 335-341; U.S. Congress, House Committee on Appropriations, Subcommittee on Labor Department and Federal Security Appropriations, Department of LaborFederal Security Agency Appropriation Bill for 1947, hearings, 79th Cong., 2nd sess., April 15, 1946 (Washington: GPO, 1946), pp. 230-237; and U.S. Congress, House Appropriations, Labor Department and Federal Security Appropriations, Department of LaborFederal Security Agency Appropriations Bill for 1948, hearings, 80th Cong., 1st sess., February 7 and 18, 1947 (Washington: GPO, 1947), pp. 273 and 368-377.

28.

Federal Security Agency, U.S. Public Health Service, Development of the Communicable Disease Center, 1946, https://globalhealthchronicles.org/files/original/151a6159652008b3bf2ce2f158a5cdc1.pdf.

29.

CDC, "About the Division of Vector-Borne Diseases," https://www.cdc.gov/ncezid/dvbd/index.html.

30.

Elizabeth W. Etheridge, "Chapter 2: The Lengthened Shadow of a Man," in Sentinel for Health: A History of the Centers for Disease Control and Prevention (University of California Press, 1992), p. 35; and John Parascandola, "From MCWA to CDC—The Origins of the Centers for Disease Control and Prevention," Public Health Reports, vol. 111 (November 1996), pp. 549-551.

31.

Federal Security Agency, "Public Health Service: Organization and Delegations of Authority," 14 Federal Register 2667, at 2672, May 20, 1949.

32.

Elizabeth W. Etheridge, "Historical Perspectives: History of CDC," Morbidity and Mortality Weekly Report, vol. 45 (June 1996), pp. 526-530; and Helen Neff, "The Center for Disease Control—1946-1976," Connecticut Medicine, 1979.

33.

CDC, "Epidemic Intelligence Service," September 2023, https://www.cdc.gov/eis/index.html.

34.

Elizabeth W. Etheridge, "Chapter 3: The Disease Detectives," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 36-66; and Jeffrey Koplan and Stephen B. Thacker, "Fifty Years of Epidemiology at the Centers for Disease Control and Prevention: Significant and Consequential," American Journal of Epidemiology, vol. 154, no. 11 (2001).

35.

CDC, "CDC Timeline 1940s-1970s," https://www.cdc.gov/museum/timeline/1940-1970.html; and Elizabeth W. Etheridge, "Chapter 8: Call to Arms," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), p. 115.

36.

Elizabeth W. Etheridge, "Chapter 6: Building the Temple," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 89-91.

37.

Helen Neff, "The Center for Disease Control—1946-1976," Connecticut Medicine, 1979; Elizabeth W Etheridge, "Historical Perspectives: History of CDC," Morbidity and Mortality Weekly Report, vol. 45 (June 1996), pp. 526-530; and D.A. Henderson, "The Development of Surveillance Systems," American Journal of Epidemiology, vol. 183, no. 5 (February 26, 2016), pp. 381-386.

38.

D.A. Henderson, "The Development of Surveillance Systems," American Journal of Epidemiology, vol. 183, no. 5 (February 26, 2016), pp. 381-386.

39.

P.L. 87-868.

40.

R. Hinman, Walter A. Orenstein, and Anne Shuchat, "Vaccine-Preventable Diseases, Immunizations, and MMWR—1961—2011," Morbidity and Mortality Weekly Report, vol. 60, no. 4 (October 7, 2011), pp. 49-57. Prior to enactment of this law, most vaccines were administered in private medical practices or by state and local health departments, generally using state and local funds with some support from the Maternal and Child Health Block grant program. In 1955, the Poliomyelitis Vaccine Assistance Act of 1955 (P.L. 84-377) authorized a grant program for the purchase and provision of polio vaccines specifically.

41.

Paul Jarris and Virginia Dolen, "Section 317 Immunization Program: Protecting a National Asset," Public Health Reports, vol. 128, no. 2 (March 2013), pp. 96-98.

42.

Alan R. Hinman, Walter A. Orenstein, and Anne Shuchat, "Vaccine-Preventable Diseases, Immunizations, and MMWR—1961—2011," Morbidity and Mortality Weekly Report, vol. 60, no. 4 (October 7, 2011), pp. 49-57.

43.

Helen Neff, "The Center for Disease Control—1946-1976," Connecticut Medicine, 1979, and David J. Sencer, "CDC's 60th Anniversary: Director's Perspective—David J. Sencer, M.D., M.P.H., 1966-1977," Morbidity and Mortality Weekly Report, vol. 55, no. 27 (July 14, 2006), pp. 745-749.

44.

Elizabeth W. Etheridge, "Chapter 13: Over Oceans and Into Space," and "Chapter 14: The Crusade Against Smallpox," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 178-187 and 188-210; and William Foege, "Centers for Disease Control," Journal of Public Health Policy, 1981.

45.

CDC, "CDC Timeline 1940s-1970s," https://www.cdc.gov/museum/timeline/1940-1970.html.

46.

Public Health Service, "Health Services and Mental Health Administration: Statement of Organizations, Functions, and Delegations of Authority," 33 Federal Register 15957, October 30, 1968.

47.

Public Health Service, "Health Services and Mental Health Administration: Statement of Organizations, Functions, and Delegations of Authority," 35 Federal Register 10797, July 1, 1970.

48.

Public Health Service, "Health Services and Mental Health Administration: Statement of Organizations, Functions, and Delegations of Authority," 35 Federal Register 10797, July 1, 1970.

49.

Jeffrey Koplan and Stephen B. Thacker, "Fifty Years of Epidemiology at the Centers for Disease Control and Prevention: Significant and Consequential," American Journal of Epidemiology, vol. 154, no. 11 (2001); Stephen B. Thacker, "Epidemiology and Public Health at CDC," MMWR, vol. 55, no. SUP02 (December 22, 2006), pp. 3-4; Elizabeth W. Etheridge, "Chapter 3: The Disease Detectives," and "Chapter 9: The Candidate for Surgeon General," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 47 and 135-136; and David J. Sencer, "CDC's 60th Anniversary: Director's Perspective—David J. Sencer, M.D., M.P.H., 1966-1977," Morbidity and Mortality Weekly Report, vol. 55, no. 27 (July 14, 2006), pp. 745-749.

50.

By the end of 1973, the U.S. Public Health Service consisted of (1) the Center for Disease Control, (2) the Food and Drug Administration, (3) the Health Resources Administration, (4) the Health Services Administration, (5) the National Institutes of Health, and (6) the Alcohol, Drug Abuse, and Mental Health Administration. Public Health Service, "Reorganization Order," 38 Federal Register 18261, July 9, 1973; and HHS Office of Administrative Management, History, Mission and Organization of the Public Health Service, 1976, https://www.google.com/books/edition/History_Mission_and_Organization_of_the/M-n4arYE5ScC?hl=en&gbpv=1.

51.

CDC, "CDC Timeline 1940s-1970s," https://www.cdc.gov/museum/timeline/1940-1970.html; William Foege, "Centers for Disease Control," Journal of Public Health Policy, 1981; and Helen Neff, "The Center for Disease Control—1946-1976," Connecticut Medicine, 1979.

52.

Elizabeth W. Etheridge, "Chapter 16: Acquisitions," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 224-234.

53.

Elizabeth W. Etheridge, "Chapter 14: The Crusade Against Smallpox," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 188-210; Elizabeth W Etheridge, "Historical Perspectives: History of CDC," Morbidity and Mortality Weekly Report, vol. 45 (June 1996), pp. 526-530; D.A. Henderson, "Smallpox Eradication," Public Health Reports, vol. 95, no. 5 (September 1980), pp. 423-426; and D.A. Henderson, "The Development of Surveillance Systems," American Journal of Epidemiology, vol. 183, no. 5 (February 26, 2016), pp. 381-386.

54.

CDC, "CDC Timeline 1940s-1970s," https://www.cdc.gov/museum/timeline/1940-1970.html; and Karen K. Steinberg, "Laboratory Science and Public Health at CDC," MMWR, vol. 55, no. SUP02 (December 22, 2006), pp. 5-6.

55.

Elizabeth W. Etheridge, "History of CDC," Morbidity and Mortality Weekly Report, vol. 45 (June 1996), pp. 526-530. In 1997, the President offered an apology for the study conducted in Tuskegee to its survivors, and the wives, family members, children, and grandchildren of the men subjected to the government's research (https://clintonwhitehouse4.archives.gov/textonly/New/Remarks/Fri/19970516-898.html).

56.

Elizabeth W. Etheridge, "Chapter 18: 1976," and "Chapter 19: Aftermath," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 247-275.

57.

Richard E. Neustadt and Harvey V. Fineberg, The Swine Flu Affair: Decision Making on a Slippery Disease, 1978, https://nap.nationalacademies.org/catalog/12660/the-swine-flu-affair-decision-making-on-a-slippery-disease.

58.

Rita Rubin, "US CDC Celebrates 70 Years," The Lancet, vol. 388, no. 10057 (November 5, 2016), pp. 2224-2225.

59.

William Foege, "Centers for Disease Control," Journal of Public Health Policy, 1981.

60.

CDC Programs and Policies Advisory Committee, Recommendations for a National Strategy for Disease Prevention, Atlanta, GA, June 30, 1978, https://stacks.cdc.gov/view/cdc/131521.

61.

U.S. Public Health Service, Healthy People: The Surgeon General's Report on Health Promotion and Disease Prevention, 1979, https://profiles.nlm.nih.gov/spotlight/nn/catalog/nlm:nlmuid-101584932X94-doc; and William Foege, "Centers for Disease Control," Journal of Public Health Policy, 1981.

62.

P.L. 96-88.

63.

Public Health Service, "Center for Disease Control; Office of the Assistant Secretary for Health Statement of Organization, Functions and Delegations of Authority," 45 Federal Register 67772, October 8, 1980. For the current official mission statement, see CDC, "Immediate Office of the Director (IOD): Mission Statement," https://www.cdc.gov/about/organization/cio-orgcharts/iod.html.

64.

Public Health Service, "Center for Disease Control; Office of the Assistant Secretary for Health Statement of Organization, Functions and Delegations of Authority," 45 Federal Register 67772, October 8, 1980.

65.

Elizabeth W. Etheridge, "Chapter 23: Toward the 21st Century," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 314-315.

66.

CDC, "CDC Timeline 1980s," https://www.cdc.gov/museum/timeline/1980.html.

67.

Elizabeth W. Etheridge, "Chapter 24: Discovery of the AIDS Epidemic," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 321-340.

68.

Elizabeth W. Etheridge, "Chapter 24: Discovery of the AIDS Epidemic," in Sentinel for Health: A History of The Centers for Disease Control, ed. University of California Press (1992), pp. 321-340; and U.S. Congress, House Committee on Government Operations, The Federal Response to AIDS, committee print, 98th Cong., 1st sess., November 30, 1983, H. Rept. 98-582.

69.

Gary R. Noble, William C. Parra, and Priscilla B. Holman, "Organizational Structure and Resources of CDC's HIV-AIDS Prevention Program," Public Health Reports, vol. 106, no. 6 (November 1991), pp. 664-667.

70.

Bernard J. Turnock, "Chapter 4: Law, Government, and Public Health," in Public Health: What it is and How it Works, 5th ed. (Jones and Barlett Learning, 2012), pp. 206-207.

71.

Gary R. Noble, William C. Parra, and Priscilla B. Holman, "Organizational Structure and Resources of CDC's HIV-AIDS Prevention Program," Public Health Reports, vol. 106, no. 6 (November 1991), pp. 664-667.

72.

P.L. 102-531.

73.

P.L. 103-66.

74.

42 U.S.C. §1396s.

75.

CRS Report R47024, Immunization Information Systems: Overview and Current Issues.

76.

P.L. 102-515.

77.

See CDC, "National Program of Cancer Registries," https://cdc.gov/cancer/npcr/index.htm.

78.

P.L. 101-354.

79.

CDC, "WISEWOMAN Frequently Asked Questions (FAQs)," https://cdc.gov/wisewoman/faqs.htm. The program's name is an acronym for "Well-Integrated Screening and Evaluation for WOMen Across the Nation."

80.

CDC, "National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP): Our Budget," https://www.cdc.gov/chronicdisease/programs-impact/budget/index.htm.

81.

See statements made at 1996 hearing: U.S. Congress, House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education, Hearing on Centers for Disease Control and Prevention Budget, 104th Cong., 2nd sess., May 1, 1996, H.Hrg 24-955 (Washington: GPO, 1996), pp. 111-392.

82.

P.L. 104-208.

83.

Found in the annual Departments of Labor, Health and Human Services, and Education, and Related Agencies (LHHS) appropriations bill. In FY2023 (P.L. 117-328), the provision read, "None of the funds made available in this title may be used, in whole or in part, to advocate or promote gun control." The title refers to the entire title that provides HHS appropriations in the LHHS law. The limitation has applied to all of HHS appropriations in the LHHS act since FY2012. Although the amendment is commonly referred to as the "Dickey amendment," Representative Jay Dickey did not introduce the amendment. Representative Dickey proposed a different amendment that did not pass in committee markup. See CQ Almanac, 104th Cong., 2nd sess., 1997, 52nd ed., 10-59-10-66., http://library.cqpress.com/cqalmanac/cqal96-841-24596-1091627.

84.

From a 2017 GAO report, "CDC officials said that after the restriction was enacted, the agency interpreted it as a prohibition of activities related to gun control advocacy, but not as a restriction of activities that supported firearm injury-related data collection and scientific research. However, CDC officials added that the agency has limited its firearm-related research over time because, in 1997, its budget was reduced by an amount equal to what the agency had spent on such research, and because it learned that further reductions were possible if the research continued." See GAO, Personal Firearms: Programs that Promote Safe Storage and Research on their Effectiveness, GAO-17-665, September 2017, p. 20, https://www.gao.gov/assets/690/687239.pdf.

85.

The appropriations limitation has applied to all HHS research since FY2012, therefore some of the studies examine effects on National Institutes of Health (NIH), CDC, and other HHS health research. David E. Stark and Nigam H. Shah, "Funding and Publication of Research on Gun Violence and Other Leading Causes of Death," Journal of the American Medical Association, vol. 317, no. 1 (January 3, 2017), pp. 84-85 and Joseph A. Ladapo, Benjamin A. Rodwin, and Andrew M. Ryan, "Scientific Publications on Firearms in Youth Before and After Congressional Action Prohibiting Federal Research Funding," Journal of the American Medical Association, vol. 310, no. 5 (August 7, 2013), pp. 532-534.

86.

CRS review of appropriations reports accessible from the CRS Appropriations Status table.

87.

House Subcommittee on LHHS Appropriations, Addressing the Public Health Emergency of Gun Violence, 116th Cong., 1st sess., March 7, 2019.

88.

See CRS Report R47400, The Strategic National Stockpile: Overview and Issues for Congress.

89.

CDC, "CDC Timeline 1990s," https://www.cdc.gov/museum/timeline/1990.html.

90.

The COVID Crisis Group, Lessons from the COVID War: An Investigative Report (New York: Public Affairs, 2023), pp. 73-74. See, for example, U.S. Congress, House Committee on Government Reform, The National Pandemic Influenza Preparedness and Response Plan: Is the United States Ready for Avian Flu? 109th Cong., 1st sess., November 4, 2005, 109-94; and CDC, "National Pandemic Strategy," https://www.cdc.gov/flu/pandemic-resources/national-strategy/index.html.

91.

P.L. 111-148, as amended.

92.

See CRS Report R41278, Public Health, Workforce, Quality, and Related Provisions in ACA: Summary and Timeline.

93.

P.L. 111-148, §4002.

94.

For more information, see CRS Report R47895, Prevention and Public Health Fund: In Brief.

95.

CDC, "CDC in Action: Working 24/7 to Stop the Threat of COVID-19," February 4, 2021, https://www.cdc.gov/budget/documents/covid-19/CDC-247-Response-to-COVID-19-fact-sheet.pdf.

96.

CDC, "Amended Order Implementing Presidential Proclamation on Advancing the Safe Resumption of Global Travel During the COVID-19 Pandemic," https://www.cdc.gov/quarantine/cruise/pdf/Vax-Order-10-30-21-p.pdf, and CRS Legal Sidebar LSB10874, COVID-Related Restrictions on Entry into the United States Under Title 42: Litigation and Legal Considerations. CDC also issued other public health orders, such as an eviction moratorium and a transportation mask mandate, that were subject to litigation and enjoined by courts. See CRS Legal Sidebar LSB10638, Supreme Court Blocks Enforcement of the CDC's Eviction Moratorium, by David H. Carpenter, and CRS Legal Sidebar LSB10589, Legal Issues Related to Transportation Mask-Wearing Mandates, by Bryan L. Adkins.

97.

See, for example, HHS Office of the Inspector General, CDC's Internal Control Weaknesses Led to Its Initial COVID-19 Test Kit Failure But CDC Ultimately Created a Working Test Kit, A-04-20-02027, October 2023, https://oig.hhs.gov/oas/reports/region4/42002027.pdf; and U.S. Congress, House Committee on Oversight and Accountability, Oversight of CDC Policies and Decisions During the COVID-19 Pandemic, 118th Cong., 1st sess., June 7, 2023.

98.

J. Stephen Morrison and Tom Inglesby, Building the CDC the Country Needs, Center for Strategic and International Studies, January 2023, https://csis-website-prod.s3.amazonaws.com/s3fs-public/publication/230112_Morrison_Building_CDC.pdf?VersionId=kTKB3urWn1bfZpXuCqixfxzHfT8AUcIM.

99.

The COVID Crisis Group, Lessons from the COVID War: An Investigative Report (New York, NY: PublicAffairs, 2023), pp. 64, 166.

100.

American Public Health Association, Testimony of Georges C. Benjamin, Executive Director at Looking Back Before Moving Forward: Assessing CDC's Failures in Fulfilling its Mission, House Energy and Commerce Committee, Subcommittee on Oversight and Investigations, June 7, 2023; Letter from Association of American Medical Colleges to The Honorable Mariannette Jane Miller-Meeks, MD, House Representative, April 21, 2023, https://www.aamc.org/media/66591/download?attachment; and Richard Besser, Comments from Richard Besser, MD on Ways to Support and Strengthen the Centers for Disease Control and Prevention, Robert Wood Johnson Foundation, April 10, 2023, https://www.rwjf.org/en/insights/advocacy-and-policy/regulatory-comments/2023/04/comments-from-richard-besser-on-ways-to-support-and-strengthen-the-cdc.html.

101.

CDC, "CDC Moving Forward Summary Report," September 2022, https://www.cdc.gov/about/organization/cdc-moving-forward-summary-report.html.

102.

CDC, "CDC Moving Forward Reorganization," 88 Federal Register 9290-9291, February 13, 2023.

103.

CDC, "CDC Moving Forward," https://www.cdc.gov/about/organization/cdc-moving-forward.html.

104.

Nancy Krieger, "Epidemiology Expands: Germs, Genes and the (Social) Environment (1900-1950)," in Epidemiology and the People's Health: Theory and Context (Oxford University Press, 2011), pp. 95-101; and Mervyn Susser, "Epidemiology in the United States After World War II," Epidemiologic Reviews, vol. 7 (1985), pp. 147-173.

105.

Jeffrey Koplan and Stephen B. Thacker, "Fifty Years of Epidemiology at the Centers for Disease Control and Prevention: Significant and Consequential," American Journal of Epidemiology, vol. 154, no. 11 (2001); and Stephen B. Thacker, "Epidemiology and Public Health at CDC," MMWR, vol. 55, no. SUP02 (December 22, 2006).

106.

Allan M. Brandt and Martha Gardner, "Antagonism and Accommodation: Interpreting the Relationship Between Public Health and Medicine in the United States During the 20th Century," American Journal of Public Health, vol. 90, no. 5 (May 2000), pp. 707-715.

107.

David S. Jones, Scott H. Podolsky, and Jeremy A. Greene, "The Burden of Disease and the Changing Task of Medicine," New England Journal of Medicine, vol. 366 (2012), pp. 2333-2338, and CDC National Center for Health Statistics, "Leading Causes of Death," https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.

108.

Mervyn Susser, "Epidemiology in the United States After World War II," Epidemiologic Reviews, vol. 7 (1985), pp. 147-173.

109.

Jeffrey Koplan and Stephen B. Thacker, "Fifty Years of Epidemiology at the Centers for Disease Control and Prevention: Significant and Consequential," American Journal of Epidemiology, vol. 154, no. 11 (2001).

110.

Allan M. Brandt and Martha Gardner, "Antagonism and Accommodation: Interpreting the Relationship Between Public Health and Medicine in the United States During the 20th Century," American Journal of Public Health, vol. 90, no. 5 (May 2000), pp. 707-715. Krista S. Crider, Yan Ping Qi, Lorraine F. Yeung, et al., "Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies," Annual Review of Nutrition, vol. 42 (August 22, 2023), pp. 423-452; and CDC National Center for Injury Prevention and Control, "Achievements in Public Health, 1900-1999 Motor-Vehicle Safety: A 20th Century Public Health Achievement," Morbidity and Mortality Weekly Report, vol. 48, no. 18, (May 14, 1999), https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4818a1.htm.

111.

Mervyn Susser, "Epidemiology in the United States After World War II," Epidemiologic Reviews, vol. 7 (1985), pp. 147-173; Safety: A 20th Century Public Health Achievement," Morbidity and Mortality Weekly Report, vol. 48, no. 18 (May 14, 1999).

112.

Public Health Service, "Center for Disease Control; Office of the Assistant Secretary for Health Statement of Organization, Functions and Delegations of Authority," 45 Federal Register 67772, October 8, 1980.

113.

For a general discussion of the interplay between congressional appropriations and administrative reorganizations, see "Appropriations as a Tool of Reorganization" and "Congressional Responses to Particular Agency Head Actions" in CRS Report R44909, Executive Branch Reorganization, by Henry B. Hogue.

114.

P.L. 117-328, Division FF, Title II; 136 Stat. 5706; 42 U.S.C. §242c.

115.

P.L. 86-158.

116.

See P.L. 93-517.

117.

U.S. Congress, House Committee on Appropriations, Conference Report to Accompany H.R. 29909, 101st Cong., 1st sess., October 6, 1989, pp. 18-19.

118.

Congressional Record, vol. 168, no. 198, book II, December 20, 2022, pp. S8877-S8881. See also CDC Operating Plan FY2023 for a summary.

119.

Institute of Medicine and National Research Council, Injury in America: A Continuing Public Health Problem, 1985, https://nap.nationalacademies.org/catalog/609/injury-in-america-a-continuing-public-health-problem. See especially page 116.

120.

P.L. 99-649.

121.

See Title III, Part J.

122.

David A. Sleet, Grant Baldwin, and Angela Marr, "History of Injury and Violence as Public Health Problems and Emergence of the National Center for Injury Prevention and Control at CDC," Journal of Safety Research, vol. 43, no. 4 (September 2012), pp. 233-247.

123.

P.L. 106-310.

124.

PHSA §317C.

125.

CDC, "CDC's National Center on Birth Defects and Developmental Disabilities Strategic Plan," February 2011, https://stacks.cdc.gov/view/cdc/11701.

126.

CDC, "Statement of Organization, Functions, and Delegations of Authority," 66 Federal Register 20148, April 19, 2001.

127.

P.L. 106-505, Title I.

128.

P.L. 106-505, §102. In 2001, anthrax spores were deliberately released through U.S. postal mail. In total, 22 people got sick and, of these, five died. See CDC, "History of Anthrax," 2020, https://www.cdc.gov/anthrax/basics/anthrax-history.html.

129.

S.Rept. 106-505.

130.

P.L. 107-188.

131.

P.L. 106-417.

132.

P.L. 113-5.

133.

P.L. 116-22.

134.

CDC, "Public Health Emergency Preparedness and Response Capabilities: National Standards for State, Local, Tribal, and Territorial Public Health," https://www.cdc.gov/orr/readiness/capabilities/index.htm.

135.

Dale A. Rose, Shivani Murthy, and Jennifer Brooks, "The Evolution of Public Health Emergency Management as a Field of Practice," American Journal of Public Health, vol. 107, no. 2 (September 2017), pp. S126-S133.

136.

P.L. 117-328; Division FF, Title II.

137.

Public Health Service Act Section 305(b)(1); 42 U.S.C. §242c(b)(1).

138.

CDC, "Immediate Office of the Director (IOD): Mission Statement," https://www.cdc.gov/about/organization/cio-orgcharts/iod.html. For Federal Register notices, see, for example, Public Health Service, "Center for Disease Control; Office of the Assistant Secretary for Health Statement of Organization, Functions and Delegations of Authority," 45 Federal Register 67772.

139.

CDC, "Mission, Role and Pledge," https://www.cdc.gov/about/organization/mission.htm.

140.

For more on this initiative, see "Current Status: The COVID-19 Pandemic and CDC's Moving Forward Initiative."

141.

CDC, "CDC Moving Forward," https://www.cdc.gov/about/organization/cdc-moving-forward.html.

142.

According to one analysis by political science scholars, 40% of federal agencies established from 1946 through 1995 were established by executive action rather than legislation; see William G. Howell and David E. Lewis, "Agencies by Presidential Design," The University of Chicago Press Journals, vol. 64, no. 4 (November 2002), pp. 1095-1114.

143.

The PREVENT Pandemics Act, P.L. 117-238, Division FF, Title II.

144.

42 U.S.C. §242c.

145.

The PREVENT Pandemics Act, P.L. 117-238, Division FF, Title II. Prior to the enactment of this statute, the CDC Director was an administratively established position.

146.

CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

147.

CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

148.

CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

149.

CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

150.

CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

151.

HHS initially established ATSDR to be headed by an Administrator who reported directly to the Assistant Secretary for Health on April 25, 1983 (48 FR 17652). On May 12, 1983, the then CDC Director became the first Administrator of ATSDR. See Richard G. Stoll, "Resolution of EDF/CMA Suit to Promote Government Health Studies," Natural Resources Law Newsletter (1983), and General Accounting Office, Interim Report on Establishment of the Agency for Toxic Substances and the Adequacy of Superfund Staff Resources, GAO/HRD-83-81, August 10, 1983, https://www.gao.gov/assets/hrd-83-81.pdf.

152.

42 U.S.C. §242s

153.

For a full list of current CDC authorizations, see CDC, "Authorizing Legislation," Congressional Justification: FY2025, pp. 49-56, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

154.

42 U.S.C. §300hh–31.

155.

42 U.S.C. §247c.

156.

CDC, "Appropriations not Authorized by Law," Congressional Justification: FY2025, pp. 58-59, https://www.cdc.gov/budget/documents/fy2025/FY-2025-CDC-congressional-justification.pdf.

157.

CRS Report R46497, Authorizations and the Appropriations Process.

158.

CDC, "FY2024 President's Budget Detail Table," https://www.cdc.gov/budget/documents/fy2024/FY-2024-CDC-Budget-Detail.pdf.

159.

CDC, "Epidemiologic Assistance," https://www.cdc.gov/eis/request-services/epiaids.html.

160.

CDC, "CDC Fiscal Year 2022 Grant Funding by State," https://fundingprofiles.cdc.gov/.

161.

Amount based on CRS analysis of CDC funding data.

162.

CDC, "Fellowships and Training Opportunities," https://www.cdc.gov/fellowships/index.html.

163.

P.L. 117-2.

164.

P.L. 117-2 §2501.

165.

The White House, "FACT SHEET: Biden-⁠Harris Administration to Invest $7 Billion from American Rescue Plan to Hire and Train Public Health Workers in Response to COVID-⁠19," press release, May 13, 2021, https://www.whitehouse.gov/briefing-room/statements-releases/2021/05/13/fact-sheet-biden-harris-administration-to-invest-7-billion-from-american-rescue-plan-to-hire-and-train-public-health-workers-in-response-to-covid-19/.

166.

CDC, "Public Health Infrastructure Grant: Recipients," https://www.cdc.gov/infrastructure/phig/funded-jurisdictions.html.

167.

CDC, "Public Health Infrastructure Grant: Grant Overview," https://www.cdc.gov/infrastructure/phig/program-overview.html.

168.

CDC, Strengthening U.S. Public Health Infrastructure, Workforce, and Data Systems (CDC-RFA-OE22-2203), CDC-RFA-OE22-2203, August 15, 2022.

169.

Lisa M. Lee and Tanja Popovic, "Preface: 60 Years of Public Health Science at CDC," MMWR, vol. 55 (SUP02), no. 1 (December 22, 2006).

170.

For an overview of public health laboratory systems, see Jay K. Varma, Jill Taylor, and Joshua M. Sharfstein, "Planning for The Next Pandemic: Lab Systems Need Policy Shift To Speed Emerging Infectious Disease Warning And Tracking," Health Affairs, vol. 42, no. 3 (March 2023).

171.

CDC, Public Health Surveillance: Preparing for the Future, September 2018, https://stacks.cdc.gov/view/cdc/58736.

172.

CDC, "Public Health Surveillance and Data: Where Does our Data Come From?" 2023, https://www.cdc.gov/surveillance/data-modernization/basics/where_does_our_data_come_from.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fsurveillance%2Fprojects%2Fdmi-initiative%2Fwhere_does_our_data_come_from.html.

173.

Association of State and Territorial Health Officials (ASTHO), Legal Landscape of Public Health Data, March 2023, https://www.astho.org/globalassets/report/legal-landscape-of-ph-data-scan-of-state-laws.pdf.

174.

Office of Management and Budget, "Statistical Programs of the United States Government: Fiscal Years, 2021/2022," https://www.whitehouse.gov/wp-content/uploads/2024/02/statistical-programs-20212022.pdf.

175.

See section "Implementation Guidance" in HHS Office of the Assistant Secretary for Planning and Evaluation, "HHS Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status," https://aspe.hhs.gov/reports/hhs-implementation-guidance-data-collection-standards-race-ethnicity-sex-primary-language-disability-0.

176.

CDC, "Health Alert Network (HAN)," https://emergency.cdc.gov/han/index.asp.

177.

See CDC, "Health Alert Network (HAN) Archive," https://emergency.cdc.gov/han/dir.asp.

178.

See program descriptions in CDC, FY2024 Congressional Justification, https://www.cdc.gov/budget/documents/fy2024/FY-2024-CDC-congressional-justification.pdf.

179.

See, for example, CDC, "Crisis & Emergency Risk Communication (CERC)," https://emergency.cdc.gov/cerc/.

180.

CRS In Focus IF12317, The Advisory Committee on Immunization Practices (ACIP).

181.

See CDC, "Violence Prevention in Practice," https://vetoviolence.cdc.gov/apps/violence-prevention-practice/#!/; and CDC, "Talking with Patients about COVID-19 Vaccination," https://www.cdc.gov/vaccines/covid-19/hcp/engaging-patients.html.

182.

Part of the federal quarantine and isolation authority over animals and other products that may transmit or spread communicable diseases is delegated to the Food and Drug Administration. See 65 Federal Register 49,906 (August 16, 2000).

183.

42 C.F.R. §§70.12–70.17.

184.

42 C.F.R. §70.2.

185.

See CDC, "Importation: Laws and Regulations," https://www.cdc.gov/importation/laws-and-regulations/index.html, and, for example, 42 C.F.R. §71.32, 42 C.F.R. §71.53, 42 C.F.R. §71.54 42 C.F.R. §71.55, 42 C.F.R. §71.56.

186.

See 42 C.F.R. Part 73 for CDC's FSAP regulations.

187.

P.L. 107-188, which added PHSA Section 351A (42 U.S.C. §262a).

188.

P.L. 95-164, as amended.

189.

For a full list of NIOSH regulations, see https://www.cdc.gov/niosh/regulations.html.

190.

The program is authorized in Social Security Act Section 1928 (42 U.S.C. §1396s).

191.

These resolutions are separate from other ACIP recommendations. See CDC, "VFC-ACIP Vaccine Resolutions," https://www.cdc.gov/vaccines/programs/vfc/providers/resolutions.html.

192.

CDC, "About VFC," https://www.cdc.gov/vaccines/programs/vfc/about/index.html.

193.

CDC, "Immunization and Vaccines for Children," CDC-RFA-IP19-1901, https://www.grants.gov/search-results-detail/309317.

194.

As defined in the Indian Health Care Improvement Act (25 U.S.C. §1603), Social Security Act (SSA) Section 1928, and CDC, "VFC Eligibility Criteria," https://www.cdc.gov/vaccines/programs/vfc/providers/eligibility.html.

195.

SSA Section 1928(c)(2)(C).

196.

CDC, FY2024 Budget Detail Table, https://www.cdc.gov/budget/documents/fy2024/FY-2024-CDC-Budget-Detail.pdf.

197.

For further information on the World Trade Center Health Program, congressional clients may contact CRS analyst Scott Szymendera.

198.

CDC, "World Trade Center Health Program: About the Program," https://www.cdc.gov/wtc/about.html.

199.

CDC World Trade Center Health Program, "Covered Conditions," https://www.cdc.gov/wtc/conditions.html.

200.

CDC World Trade Center Health Program, "About the Program," https://www.cdc.gov/wtc/about.html.

201.

P.L. 111-347.

202.

U.S. Government Accountability Office, World Trade Center Health Program: Potential Effects of Implementation Options, GAO-11-735R, August 4, 2011, https://www.gao.gov/products/gao-11-735r.

203.

See information on spending in documents linked at CDC, "Congressional Justifications," https://www.cdc.gov/budget/congressional-justifications/index.html. For annual appropriated amounts, see PHSA Section 3351 (42 U.S.C. §300mm-61).

204.

Congress provided an additional $1 billion for a Supplemental Fund in Consolidated Appropriations Act, 2023 (P.L. 117-329) In the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-131), Congress provided and additional $444 million in supplemental funding to be available through FY2033 and $232 million in supplemental funding to provide services to the pool of Pentagon and Shanksville responders expanded by a provision in P.L. 118-131.

205.

CDC, "FY2024 Budget Detail Table," https://www.cdc.gov/budget/documents/fy2024/FY-2024-CDC-Budget-Detail.pdf.

206.

See, for example, Brian J. Miller, Niraj Gowda, Padmini Ranasinghe, et al., "A Vision for Supporting And Reforming The CDC," Health Affairs, June 10, 2022; Scott Gottlieb, "Opinion: How to Fix the CDC: First, Make it Smaller," The Washington Post, January 19, 2023; and U.S. Congress, House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, Looking Back Before Moving Forward: Assessing CDC's Failures in Fulfilling its Mission, 118th Cong., 1st sess., June 7, 2023.

207.

Sen. Cassidy, Senate HELP Committee, "Ranking Member Cassidy Seeks Information from Stakeholders on CDC Reform," press release, September 26, 2023, https://www.help.senate.gov/ranking/newsroom/press/ranking-member-cassidy-seeks-information-from-stakeholders-on-cdc-reform; and House Committee on Energy and Commerce, "Rep. Miller-Meeks Seeks Stakeholder Feedback to Reform CDC Following Years of Consistent Failures and Broken Trust," press release, April 5, 2023, https://energycommerce.house.gov/posts/rep-miller-meeks-seeks-stakeholder-feedback-to-reform-cdc-following-years-of-consistent-failures-and-broken-trust.

208.

PHSA Section 305(b)(1); 42 U.S.C. §424c(b)(1).

209.

See, for example, Brian J. Miller, Niraj Gowda, Padmini Ranasinghe, et al., "A Vision for Supporting And Reforming The CDC," Health Affairs, June 10, 2022; Scott Gottlieb, "Opinion: How to Fix the CDC: First, Make it Smaller," The Washington Post, January 19, 2023; and Dr. Joel M. Zinberg and Drew Keyes, Unauthorized and Unprepared: Refocusing the CDC After COVID-19, Paragon Health Institute, July 2023, https://paragoninstitute.org/wp-content/uploads/2023/07/Unauthorized-and-Unprepared-Refocusing-the-CDC-after-COVID-19_Zinberg-Keyes_FOR-RELEASE_V1.pdf.

210.

U.S. Congress, House Committee on Oversight and Accountability, Oversight of CDC Policies and Decisions During the COVID-19 Pandemic, 118th Cong., 1st sess., June 13, 2023.

211.

See, for example, Richard Besser, Comments from Richard Besser, MD on Ways to Support and Strengthen the Centers for Disease Control and Prevention, Robert Wood Johnson Foundation, April 10, 2023, https://www.rwjf.org/en/insights/advocacy-and-policy/regulatory-comments/2023/04/comments-from-richard-besser-on-ways-to-support-and-strengthen-the-cdc.html; and Letter from Lori Tremmel Freeman, MPA, CEO, National Association of County and City Health Officials to The Honorable Bill Cassidy, ranking member, Senate Committee on Health, Education, Labor and Pensions, October 20, 2023, https://www.naccho.org/uploads/downloadable-resources/10.20.2023-NACCHO-Response-to-Cassidy-RFI-on-CDC.pdf.

212.

The Infectious Diseases Society of America and the HIV Medicine Association, Reform of the Centers for Disease Control and Prevention, 2023, https://www.idsociety.org/globalassets/idsa-cdc-rfi-final.pdf.

213.

See CDC, "Health Alert Network (HAN) Archive," https://emergency.cdc.gov/han/dir.asp.

214.

See Deborah W. Gould, David Walker, and Paula W. Yoon, "The Evolution of BioSense: Lessons Learned and Future Directions," Public Health Reports, vol. 132 (July 2017), pp. 7S-11S.

215.

CDC, "CDC Moving Forward Summary Report," https://www.cdc.gov/about/organization/cdc-moving-forward-summary-report.html.

216.

See CDC, "COVID-19 Vaccination Program Interim Operational Guidance Jurisdiction Operations," October 29, 2020, https://www.cdc.gov/vaccines/imz-managers/downloads/Covid-19-Vaccination-Program-Interim_Playbook.pdf.

217.

CDC, "Moving Forward Summary Report," September 2022, https://www.cdc.gov/about/organization/cdc-moving-forward-summary-report.html.

218.

UK Department of Health and Social Care, "Policy Paper: Transforming the Public Health System," May 29, 2021, https://www.gov.uk/government/publications/transforming-the-public-health-system.

219.

GAO, Public Health Preparedness: Critical Need to Address Deficiencies in HHS's Leadership and Coordination of Emergencies, GAO-23-106829, May 11, 2023, https://www.gao.gov/assets/gao-23-106829.pdf.

220.

Public Health Service Act Section 2811; 42 U.S.C. §300hh-10.

221.

American Public Health Association, Testimony of Georges C. Benjamin, Executive Director at Looking Back Before Moving Forward: Assessing CDC's Failures in Fulfilling its Mission, House Energy and Commerce Committee, Subcommittee on Oversight and Investigations, June 7, 2023, p. 32.

222.

Letter from Michael R. Fraser, CEO, Association of State and Territorial Health Officials to Sen. Bill Cassidy, ranking member, Senate Committee on Health, Education, Labor, and Pensions, October 20, 2023, https://www.astho.org/globalassets/pdf/government-affairs/astho-responds-to-senate-help-rfi-on-cdc-reform-october-2023.pdf.

223.

CDC, "Moving Forward Summary Report," September 2022, https://www.cdc.gov/about/organization/cdc-moving-forward-summary-report.html.

224.

J. Stephen Morrison and Tom Inglesby, Building the CDC the Country Needs, Center for Strategic and International Studies, January 2023, https://csis-website-prod.s3.amazonaws.com/s3fs-public/publication/230112_Morrison_Building_CDC.pdf?VersionId=kTKB3urWn1bfZpXuCqixfxzHfT8AUcIM.

225.

Brian J. Miller, Niraj Gowda, Padmini Ranasinghe, et al., "A Vision for Supporting and Reforming The CDC," Health Affairs, June 10, 2022

226.

Letter from Michael R. Fraser, CEO, Association of State and Territorial Health Officials to Sen. Bill Cassidy, ranking member, Senate Committee on Health, Education, Labor, and Pensions, October 20, 2023, https://www.astho.org/globalassets/pdf/government-affairs/astho-responds-to-senate-help-rfi-on-cdc-reform-october-2023.pdf.

227.

Dr. Joel M. Zinberg and Drew Keyes, Unauthorized and Unprepared: Refocusing the CDC After COVID-19, Paragon Health Institute, July 2023, https://paragoninstitute.org/wp-content/uploads/2023/07/Unauthorized-and-Unprepared-Refocusing-the-CDC-after-COVID-19_Zinberg-Keyes_FOR-RELEASE_V1.pdf; and Letter from Academy of General Dentistry to The Honorable Mariannette Miller-Meeks, MD, Representative, House Committee on Energy and Commerce, April 23, 2023, https://www.agd.org/docs/default-source/advocacy-papers/agd-miller-meeks-letterhead-cdc-rfi_.pdf?sfvrsn=1904d33c_0.

228.

Letter from Joel M. Zinberg, MD, JD, Drew Keyes, to The Honorable Mariannette Miller-Meeks, Representative, Committee on Energy and Commerce, May 2023, https://paragoninstitute.org/wp-content/uploads/2023/05/CDC-RFI_ParagonHealthInstitute-230503.pdf.

229.

CRS Report R45015, Minority Business Development Agency: An Overview of Its History and Current Issues; Department of the Interior, Bureau of Safety and Environmental Enforcement, "Organizational History," at https://www.bsee.gov/about-bsee/our-organization/organizational-history; and Darrel J. Grinstead, "Appendix H: Statutory Framework for the Organization and Management of the U.S. Department of Health and Human Services," in HHS in the 21st Century: Charting a New Course for a Healthier America (The National Academies Press, 2009).

230.

William G. Howell and David E. Lewis, "Agencies by Presidential Design," The University of Chicago Press Journals, vol. 64, no. 4 (November 2002), pp. 1095-1114.

231.

Dr. Joel M. Zinberg and Drew Keyes, Unauthorized and Unprepared: Refocusing the CDC After COVID-19, Paragon Health Institute, July 2023, https://paragoninstitute.org/public-health/unauthorized-unprepared-refocusing-cdc-after-covid19/; Brian J. Miller, Niraj Gowda, Padmini Ranasinghe, et al., "A Vision for Supporting And Reforming The CDC," Health Affairs, June 10, 2022; and Scott Gottlieb, "Opinion: How to Fix the CDC: First, Make it Smaller," The Washington Post, January 19, 2023

232.

CDC Office of Readiness and Response, "CDC Agency-wide Responses," https://www.cdc.gov/orr/timeline/cdc-response-events.html; and CDC, "CDC's Efforts to Prevent Overdoses and Substance Use-Related Harms," https://www.cdc.gov/drugoverdose/prevention/pdf/CDC-Efforts-to-Prevent-Overdoses_2022-2024.pdf.